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1. Introduction
1.1 Classification and prevalence of obesity
The World Health Organization (WHO) defines obesity as a disease in which excessive body 
fat has accumulated to such an extent that health may be adversely affected [1]. When 
comparing the prevalence of the disease across cultures, we need a classification and 
standardized measurements. The Body Mass Index (BMI) [1] is one common measure used 
to assess the degree of overweight and obesity.  BMI is defined as weight in kilograms 
divided by the square of height in metres (kg/m2). On the basis of epidemiological studies, the 
WHO has concluded that a BMI between 18.5 and 25 kg/m2 is to be considered “normal 
weight”, a BMI between 25 and 30 kg/m2 is to be considered “overweight”, whilst a BMI 
score  30 kg/m2 is to be considered “obese” [1]. Morbid obesity LVXQGHUVWRRGDVD%0,
kg/m2 RU 35 kg/m2 with at least one comorbidity [2]. A comorbidity is understood as any 
condition associated with obesity that usually worsens as the degree of obesity increases and 
that often improves as the condition is treated [3, 4].
The amount of excess fat, its distribution within the body, and the associated health 
consequences vary considerably between obese individuals. BMI does not discriminate 
between weight associated with muscles and weight associated with fat mass, nor with the fat 
distribution within the body. In this sense, well-trained individuals may have scores on the 
BMI-index indicating overweight or even obesity without having an abnormal or excessive 
body-fat accumulation. The WHO has outlined some of the other weaknesses associated with
BMI measurements [1, 5], drawing specific attention to the fact that BMI may not correspond 
to the same percentage of body-fat across populations. Even with an identical BMI, 
Polynesians tend to have a lower percentage of body-fat than Caucasian Australians [6]. The 
percentage of body-fat, especially abdominal fat, also tends to increase with age in both sexes 
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[7], and is generally higher in women than in men [8]. In spite of these weaknesses, the WHO 
has proposed using BMI for epidemiological research in order to measure the potential health 
hazardous fat accumulation in individuals [1, 5]
The WHO has declared that the incidence of obesity has reached epidemic proportions [1],
and a 2011 meta-analysis published in The Lancet reported nearly a doubling of obesity 
worldwide as measured by BMI: approximately 5% (men) and 8% (women) in 1980 to 10% 
(men) and 14% (women) in 2008 [9].
The prevalence of obesity in Norway has tripled between 1960 and 2000 [10]. A number of 
Norwegian studies have provided epidemiological data; the Nord-Trøndelag Health Study 
(“Helseundersøkelsene i Nord-Trøndelag”, HUNT) consists of three surveys (1984-86, 1995-
97 and 2006-08). The three surveys show how obesity increased from approximately 14% to 
19% to 23% in women, and from 8 % to 14% to 22% in men. The prevalence of extreme 
REHVLW\%0,NJP2) was .5% in men and 1.5% in women (2006-2008) [11]. This 
development is similar to that of other countries, but not as far-reaching as in the USA. In the 
USA the prevalence of obesity in 1999-2000 (as measured by BMI) was 28% (men) and 33% 
(women). In 2009-2010 the prevalence had raised to 36% in both men and women. The 
prevalence of extreme obesity (%0,NJP2) in the USA was 4% in men and 8% women 
(2009-2010) [12].
There is comprehensive evidence that abdominal adiposity represents an increased risk of 
illness and premature death [5, 13, 14]. Abdominal adiposity refers to a large proportion of
fat mass situated around the intestines and in the liver. On the basis of such evidence the 
WHO proposes that measurements of waist circumference (WC) be applied as a primary 
individual measure of overweight and obesity. As with BMI, there are cut-off values relating 
to the level of health risk. Utilising a Dutch study [15] of 2183 men and 2698 women aged 
8 
 
20-59 years, the WHO proposes a WC of 94 cm and 102 cm for Caucasian men, and a WC of
80 cm and 88 cm in women. These figures are thresholds for increased or substantially 
increased risk of metabolic complications associated with obesity [5].
The increase of WC in Norway is alarming. The HUNT study [11] found that mean (SD) WC 
among women increased from 81.4 (11.4) to 90.3 (12.7) cm in  HUNT 2 (1995-97 ) and 
HUNT 3 (2006-08). The corresponding WC increase amongst men was 91.9 (9.3) to 97.4 
(10.5) cm. In HUNT 3, abdominal obesity :&102 cm in men and 88 cm in women),
which indicates a substantially increased risk of metabolic consequences, was found in 56%
of women compared to 32% of men. The findings from the HUNT 3 study indicate that severe 
obesity has also become a concerning health issue in a Norwegian context [11].
1.2 Causes of obesity
The academic literature points to many different explanations for this epidemic of obesity.
Some diseases and syndromes may cause obesity, whilst we know that certain medicines,
such as psychotropic drugs [16] and oral contraceptives [17], are associated with weight gain. 
Genes do play a role [18, 19]. Genes regulate the capture, storage and release of energy from 
food and this genetic function is a prerequisite for our survival, both as individuals but also of 
humans as a species. Our genetic regulatory system seems to be designed to create fat 
storages to be used as energy depots in times of food scarcity. For most people, in 
environments with a food surplus, our genetic mechanisms do not seem to have the same 
appropriate regulatory functions; the genetic system does not impose fat reduction – only the 
opposite.  The variance between different individuals in terms of their susceptibility to weight 
gain may be explained by a gene-environment interaction  [20]. This refers to a situation 
where the effect of an individual’s behaviour on weight gain is influenced or modified by the
individual’s genetic composition [20].  However, the genetic composition of the population 
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does not change rapidly. The large increase in the prevalence of obesity during the last few
decades must thus reflect changes in other factors than human genetics [19].
The most prominent environmental explanations accounting for the increased prevalence of 
obesity are related to an efficient food energy supply increasing the energy intake, combined 
with a decrease in physical activity related to more effective means of transportation and the
mechanisation of  working life [19]. In the literature the use of “obesogenic environment” has 
become commonplace. An obesogenic environment represents the created general working 
and living conditions which promote excessive food-intake and demotivate individuals from 
engaging in physical activity [21]. Reduced physical activity and changes in the global food 
system, including reductions in the time-cost of food, seem to be the major drivers of the rise 
of the global obesity epidemic [19]. Other factors (sleep debt, endocrine disruptors, reduction 
in variability of ambient temperature, decreased smoking, changes in distribution of ethnicity 
and age, higher age at first pregnancy, epigenetics, and natural selection of obesity specific 
genotypes) have been discussed as additional explanations to the obesogenic factor [22, 23].
1.3 Consequences of obesity
The link between obesity and disease was first acknowledged by the ancient Greeks, with 
Hippocrates as a forefather also in this perspective [24]. Following the increased prevalence 
of obesity, the volume of research on obesity’s consequences has grown rapidly over the past
few decades. It is now widely recognised that obesity, and especially abdominal adiposity [13, 
14], is a major contributing factor in the development of chronic diseases like type 2 diabetes 
mellitus, hypertension, obstructive sleep apnoea, cancer, heart and vascular diseases, 
gallbladder disease as well as a number of other disorders [4, 25-28]. Morbid obesity is also 
associated with higher mortality [29, 30], increased psychological distress [31-36] and 
impaired quality of life [32, 37-45].
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1.3.1 Quality of life
Quality of Life (QOL) is a broad concept and refers to how well an individual functions in 
daily life and his or hers perceived well-being [46]. The concept can be related to many areas 
of life, with most people having an intuitive understanding of their personal QOL in regard to 
such areas. 
The definition of QOL varies. WHO has defined health as a state of complete physical, 
mental and social well-being, and not merely the absence of disease or illness [47]. The 
multidimensionality of health is noteworthy, and a WHO work group has identified the 
following cross-cultural elements to QOL: physical health, mental health, social relationships, 
environment, as well as overall QOL [48].
To distinguish between the general concept of QOL in clinical and health research the term 
health-related quality of life (HRQL) is frequently used [49]. The most common 
understanding of HRQL is that it is a multidimensional measurement of the impact an illness 
and/or its treatment has on individuals [50, 51]. To clinicians, researchers and scholars 
occupied with problems relating to health, well-being and illness, HRQL is of special interest 
as it reflects an individual’s subjective response and assessment of his or her state of health. 
The multidimensionality of the concept opens for investigations into different areas or 
dimensions; physical, mental, emotional and social to name only a few [52].
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Measurement of quality of life
While studies of QOL and HRQL can be performed using qualitative research methods [53],
measurements of HRQL are largely quantitative and achieved through standardized 
questionnaires (instruments) which assess the different aspects of HRQL.
There are two basic approaches to quantitative HRQL assessments [37]. The first involves the 
use of instruments that measure broad and generalized aspects of HRQL (generic 
instruments). The second approach to HRQL assessment involves the use of instruments that 
are specific to a disease (eg. obesity), population (eg. adolescents or adults), and/or clinical 
problem (eg. sexual function, pain). 
Different instruments have been developed in defined cultural settings with samples 
representing specific populations. When selecting an instrument for research purposes, it is 
important that the instrument is validated for use in the culture and population in question, as
well as for the clinical problem it is intended to be used in.
Generic instruments
The main advantage of generic instruments is that they allow comparisons both between 
diagnostic groups as well as between diagnostic groups and the general population.  The main 
drawback with generic measures is that it is not possible to determine if respondents attribute 
their HRQL to their specific disease (eg. obesity) or to other factors (eg. age or a comorbid 
condition such as diabetes). There are many generic instruments, though the most commonly 
used in health (and societal) research is the Medical Outcomes Study Short-Form-36 (SF-36)
(appendix 1).
SF-36 is based on 36 items [54-56]. Item 2 is not included in the scoring of the instrument 
[56] and is a question on health change over the last 12 months. The remaining 35 items are
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scored into eight domains (physical function, role physical, bodily pain, general health, role 
emotional, social function, vitality, and mental health) which can be combined into two 
summary scores; the physical and mental dimensions [57]. The scoring and calculations are 
standardized by the scale authors [57]. There has been raised criticism on the scoring of the 
two main dimensions [58, 59] [58-60] on which type of factor score that should be applied 
and different alternatives have been suggested [61].
The SF-36 was developed in conjunction with the 1988-89 US Medical Outcomes Study [62].
Outcomes included end points such as physical, social, and role functioning in everyday life,
and patients' perceptions of their general health and well-being and satisfaction with their
treatment. Adult patients (n = 22,462) evaluated their health status and treatment. A sample of 
these patients (n = 2,349) with diabetes, hypertension, coronary heart disease, and/or 
depression were selected for further longitudinal studies and formed the basis for the 
development of the instrument [54]. Thereafter the instrument has become the most widely 
used generic HRQL instrument, and according to the website of the SF-36 stakeholders [63] it
has been documented in more than 4000 publications. The instrument has been validated for 
many diagnostic groups and translated into more than 22 languages. 
The validity of the instrument in a morbidly obese population has not been properly tested, 
but a 2006 Italian observational multicentre validation study of 1735 obese outpatients of 
whom 60% had a BMI  35 kg/m2 raises some questions [64]. A principal component 
analysis (PCA) with an oblique rotation suggested a 6-component solution instead of the 
original 8-component solution, thereby questioning the construct validity of the 8 SF-36
subscales in patients with obesity. The study found a peculiar clustering of some SF-36 items 
and their relationship with BMI, suggesting that the HRQL profile of subjects belonging to 
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that population may be better described with alternative aggregations of the SF-36 items or 
with disease-tailored questionnaires. The study did not assess the structural validity of the two
summary scales [64].
Disease-specific instruments
Disease-specific instruments contain questions (items) that reflect the most relevant 
characteristics or problems connected to a specific disease or condition. There are several 
obesity specific HRQL-instruments [52, 65]. Examples of well-designed and validated 
weight-specific HRQL measures are the Obesity and Weight Loss Quality of Life 
Questionnaire (OWLQOL) (appendix 2) and the Weight-Related Symptom Measure (WRSM) 
(appendix 3) [66, 67].
The OWLQOL questionnaire is developed by the University of Washington between the 
years 2000 and 2004 [66, 67]. The scale authors used a theoretical model for perceived HRQL 
to identify and select items that assessed emotional feelings in persons with obesity [52, 65].
The instrument consists of 17 statements about weight-related feelings and emotions which 
are rated on a seven-point scale that ranges from 0 (“not at all”) to 6 (“very large”). The 17 
items of the OWLQOL form a scale ranging from 0-102, with higher scores indicating a
better emotional HRQL. 
Validation studies of the OWLQOL have been performed in the US, Italy and France 
(n = 6,107). Mean BMI in these three studies varied from 33-37 kg/m2, whilst age varied from 
45-51 years and the proportion of females from 40-82%. The studies concluded that the 
instrument were brief, valid, reproducible and responsive on measurement of self-reported 
outcomes in obesity [67].
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The WRSM questionnaire was produced in conjunction with the OWLQOL and was validated 
in the same studies reported above [66, 67]. The instrument measures twenty obesity specific 
symptoms using two different sets of items. 
The first set of items assesses whether or not the patient is experiencing specific symptoms. 
The scoring of this set of items creates an additive scale summing up the number of 
symptoms, ranging from 0–20. The second set of items concerns the distress symptoms
impose, with values from 0 (“not at all “) to 6 (“very large“). They form a symptom distress 
scale ranging from 0–120, where higher scores indicate worse symptom distress. 
1.3.2 Physical functioning and HRQL in morbid obesity
Impaired physical functioning in morbidly obese persons is most likely caused by continuous 
increased strain on the musculoskeletal, respiratory and cardiovascular systems. Obesity, and 
especially abdominal adiposity, is associated with increased pressure on organs due to fat 
mass, making breathing difficult and decreasing the flexibility of body movements. However, 
the metabolic effects of obesity may also have a have an additional degenerative effect on the 
development of comorbidities and musculoskeletal pain [68].
A Swedish study (n = 5,633) applying the SF-36 reported that overweight and obesity in 
young (16-34 years) men and women had a largely negative effect on physical health. Among 
the middle-aged (35-64 years), obese women reported more physical HRQL-impairments 
[mean (SE) 79 (2) points] than  obese men [mean (SE) 87 (1) points] [38]. This finding is 
consistent with the findings of a study review which explored the influence of obesity on 
HRQL. The authors concluded that obesity-associated detrimental effects on HRQL tend to 
be most pronounced in physical domains regardless of the applied HRQL-instruments [37].
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There is a significant association between increasing BMI and impaired physical HRQL,
where individuals with morbid obesity have the lowest scores on physical HRQL [37, 43] and 
physical functioning measures [69]. Adequate walking capacity and physical stamina are 
important elements of an individual’s physical HRQL, and data based on time to exhaustion 
while walking on a treadmill have shown that the prevalence of individuals with low 
cardiorespiratory fitness increases by about 5 % per unit increase of BMI above 25 
kg/m2 [69].  Common physical problems in morbidly obese individuals include doing 
moderate/vigorous activities, an inability to climb stairs, carrying groceries, walking long 
distances, trouble bending down, inability to tie shoe laces and difficulty getting up from 
chairs. These may all affect the activities of daily living (ADL). The physical limitations can 
be especially troublesome when obesity is associated with sweating, urine incontinence and 
skin problems. Such ADL limitations may become so severe that basic self-care becomes 
difficult, especially for the morbidly obese. Obesity, especially morbid obesity, is also a risk 
factor for musculoskeletal pain, which may impair physical functioning and general well-
being [68, 70-73].  Impaired physical functioning can result in low vitality [37, 43] and an
impaired ability to fill social roles in daily life such as participating in paid work, parenting, 
housework and hobbies. 
1.3.3 Social and emotional functioning and HRQL in morbid obesity
One of the greatest social challenges faced by morbidly obese persons is the stigma associated 
with the condition [32, 74]. The ancient Greeks used the term stigma to refer to the scarring or 
burn marks imprinted onto slaves, criminals or traitors to symbolize their societal status. 
Today, the term is used in a similar but more subtle way. The Canadian sociologist Erving 
Goffman’s theoretical framework on stigma [75] and social interaction [76] explains the 
phenomenon of stigma as the categorization of an individual into a discrediting social 
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identity.  According to Goffman, the (external) stigma of the individual will be internalized as 
the individual eventually accepts his or hers stigma, even though it is discrediting. In obesity, 
this internalization of (external) stigma may lead to an acceptance of having an undesirable 
body appearance and its implied character defects. This may in turn lead to the poor social 
interaction and impaired emotional quality of life that many morbidly obese individuals 
report. 
The prejudice and stigma directed against obese individuals begins early in life. In 1967, J. 
Robert Staffieri reported anti-fat attitudes among 90 boys aged 6-10 years old [77]. The 
children were to apply 39 different adjectives to 3 silhouettes (thin, normal and overweight). 
The overweight silhouette was characterized as “cheats”, “lies”, “argues”, “lazy”, “sloppy”, 
“mean”, “dirty”, “ugly”, and “stupid” by the children. Later studies have produced similar 
results [78, 79]. Even studies of health personnel show anti-fat attitudes [80-82]. Such anti-fat 
attitudes among health personnel can make morbidly obese individuals reluctant to seek 
medical assistance for their condition and for the comorbidity associated with obesity. One 
Swedish population based study reported that obese individuals were twice as likely to report 
healthcare discrimination as healthy weight individuals [83], with the same  reported in 
several other studies  [84-86], suggesting that  health care workers also stigmatize their obese 
patients.  
A UK study of randomly selected subjects (n = 13,800, response rate 64%) applied the SF-36
[87] and found that overweight and obesity were associated with decreasing levels of both 
physical and emotional well-being. The authors also found that this deterioration in health 
status was more evident in the physical than mental dimension. In the mental and social 
domains overweight and obese subjects scored no less than underweight subjects. However, 
generic instruments like the SF-36 may not be tailored to measure mental, social and 
emotional HRQL in obesity. A study applying a disease specific instrument (OWLQOL) in
17 
 
6107 obese subjects in the USA, Italy and France found that obese women had a consistently 
lower emotional HRQL than men (regardless of age or culture) and that the deterioration of 
emotional HRQL was significantly associated with increasing BMI [67]. Studies of another 
disease specific instrument (Impact of Weight on Quality of Life - IWQOL) have shown 
similar results [42, 43, 88]. These findings underscore the gender differentiated association 
between increasing BMI and decreased emotional HRQL. These studies also illustrate the 
importance of combining generic and disease specific instruments in clinical HRQL research.
1.3.4 Mental health and HRQL in morbid obesity
While many morbidly obese individuals have a good mental health, a number of studies have 
shown significant associations between obesity and impaired mental health. This impairment 
encompasses both a wide range of psychiatric diagnoses and minor disturbances. In a 
nationally representative sample of US residents (n = 9,125, 26% BMI  30 kg/m2), obesity 
was associated with an approximately 25% increase in mood and anxiety disorders as well as
an approximately 25% decrease in substance use disorders [34]. The prevalence of eating 
disorders is generally high in the obese population, especially Binge Eating Disorder (BED) 
and Bulimia Nervosa (BN). The WHO World Mental Health Surveys found that in people 
with BMI  40 kg/m2, 7.6% reported BES and 5.6% BN over the last 12 months [89]. It has 
been hypothesized [36] that mood disorders, especially depression, are potentiated in the 
morbidly obese due to greater prejudice, discrimination and stigma. In one US study of a
nationally-representative sample [33] the BMI-depression relationship varied in terms of
gender. There were no significant associations between BMI and depression among men, 
while women with the highest BMI’s (BMI  29 kg/m2) were 38% more likely to score in the 
depressed range than women with lower BMI’s. A second US population study [31] found 
that obese women were 37% more likely than normal weight women to have experienced 
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major depression in the past year. Obese women also reported more suicidal ideation and 
were more likely to have made a suicide attempt in the past year. 
The association between mood disturbances and impaired HRQL Is shown in a cross-
sectional study of 306 morbidly obese individuals [90]. 46% had a BMI of 40-49.9 kg/m2,
34% a BMI of 50- 59.9 kg/m2DQG%0,NJP2. Impaired HRQL was defined as a 
score of 1 SD below national means. Of all participants, impaired HRQL, as measured with 
the SF-36, was found in 78% (physical functioning), 45% (physical role limitations), and 52% 
(bodily pain). Depression was assessed by Becks Depression Inventory [91]. The authors 
found that these three HRQL-scales were significantly associated with symptoms of 
depression (all p < .001). BMI was not related to depression and the interaction of BMI and 
HRQL impairment was not found to be significant. [90]. The authors concluded that 
impairments to the completion of everyday activities, the experience of significant pain and
the difficulty of fulfilling occupational roles were stronger determinants of mood disturbance 
than the severity of obesity. Similar results are found in other studies [35, 44, 92-94].
In sum, such studies show that obese individuals, particularly females and those individuals 
with morbid obesity are at risk of developing psychological distress, especially eating 
disturbances and depression, even though such distress does not necessarily rise to the level of 
a formal psychiatric diagnosis. As described above, being obese is a source of stigmatization, 
while the social pressure to conform to norms of thinness may be internalized and lead to high 
levels of psychological distress. Eunkyung Park [95] suggests that gender may function as a 
moderator by exerting more sociocultural pressure on women  to conform to an idealized 
physique, subsequently leading to mood and depressive disorders. 
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1.3.5 Work related factors and HRQL
Obese individuals have greater problems in job settings than normal weight individuals [32].
A 2011 Swedish study demonstrated that obesity stereotypes amongst 153 managers predicted 
labour market discrimination in hiring situations [96]. The authors found a strong and 
consistent relationship between managers’ anti-obesity bias and the probability that they 
would invite a normal-weight, but not an obese, job applicant for an interview [96].
Another Swedish study of 5019 individuals found that severely obese women reported greater 
workplace discrimination than obese men and normal weight women. 29% of the moderately 
obese included in the study (n = 1,235, BMI 30-34.9 kg/m2) reported workplace 
discrimination. Among the severely obese (n = %0,NJP2) this figure was 33%. 
Compared to normal weight women (BMI 18.4-24.9 kg/m2), moderately obese women had an 
adjusted OR (95% CI) of 1.23 (.93-1.70) of reporting workplace discrimination, while 
severely obese women had an OR (95% CI) of 1.97 (1.48-3.10). The OR (95% CI) for 
moderately obese men (n = 628) was 1.65 (1.18-2.30) and amongst severely obese men (n =
119) the OR (95% CI) was 1.17 (.69-1.97). [83].
There are also significant associations between obesity and sick leave. A review of 36 studies 
exploring the association between obesity and sick leave showed differences between 
countries [97]. In US studies, obese workers had about 1–3 extra days of absence per person
per year compared with their normal-weight counterparts. In European studies, the 
corresponding difference was about 10 days. The study also showed a J-shaped relationship 
between BMI and the risk for a disability pension [97], indicating that underweight and obese 
persons have an increased risk of being unemployed. Obesity would thus seem to have 
consequences for the ability of obese subjects to both access and retain paid work. These 
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consequences affect both the individuals in question and their families, adding to the general
burden of life as well as other obesity related problems [97, 98].
There has been little focus on the association between employment and HRQL in morbidly 
obese. A Norwegian study of 51 morbidly obese subjects treated with duodenal switch [98]
demonstrated a statistically significant association between employment and the physical and
mental dimensions of the SF-36. The study was, however, limited by a lack of adjustments for 
obesity-related comorbidities and conditions which might have influenced HRQL. In addition, 
no obesity-specific measure of HRQL was addressed.
1.4 Treatment of morbid obesity
The cornerstone of obesity treatment is behaviour change. Morbid obesity treatment can take 
the form of either a pharmaceutical, surgical or lifestyle intervention. Various pharmaceutical 
products have been plagued with safety concerns or patient non-adherence due to the 
unpleasant side-effects, with several promising products not receiving approval from the 
regulatory agencies in the US and EU. However, pharmacological research is intensive and 
several new products are in the pipeline and awaiting testing and approval [99].
1.4.1 Bariatric surgery
In 1952 the Swedish surgeon Viktor Henrikson conducted the first reported bariatric 
procedure when he performed a small bowel partial resection, and was followed in 1954 by
the US surgeon Arnold J. Kremen who conducted jejuno-ileal bypass [100]. Since these initial 
procedures bariatric surgery has gained popularity, with Roux-en-Y Gastric Bypass (RYGB) 
accounting for > 90% of bariatric procedures in Norway [101] and  > 50% worldwide [102, 
103].  A Cochrane database systematic review of bariatric surgery published in 2009 found 
only limited evidence of the efficacy of RYGB when compared to four other bariatric 
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procedures [103]. Nevertheless, RYGB is regarded as the “gold standard” of bariatric surgery 
[103].  RYGB is a combined restriction and malabsorption technique, where the surgeon first 
divides the stomach into a small, proximal pouch and a separate, large, distal remnant (figure 
1). The upper pouch is joined to the proximal jejunum through a narrow Roux-en-Y
gastrojejunal anastomosis. As a result of the procedure the storage capacity of the stomach 
reduces to approximately 5% of its normal volume, with ingested food bypassing
approximately 95% of the stomach, the entire duodenum, and a small portion (15–20 cm) of 
the proximal jejunum  [104] .
Figure 1. Gastric bypass 
Illustration by Ole-Jacob Berge. Reproduced from Aasheim et al. [101] with permission.
The small gastric pouch forces the patient to eat carefully, with over-eating leading to 
stomach pain and/or vomiting/regurgitation. The 100-150 cm bypass of the proximal ileum 
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leads to reduced absorption of fat and other nutritional elements. In addition to these effects, 
the bypass of the stomach leads to a lower expression of appetite stimulating hormones such
as ghrelin, as well as an increase in anorectic gut hormones such as glucagon-like peptide-1
and peptide YY [104-106]. Laparoscopic surgical techniques have fewer complications than 
open surgery, and today >90% of bariatric procedures are performed laparoscopically [107].
The Swedish Obese Subjects (SOS) study included 2010 obese subjects  undergoing bariatric 
surgery [RYGB (13%), gastric banding (19%) and vertical banded gastroplasty (68%)], as 
well as 2037 contemporaneously matched obese control subjects receiving standard care. 
When comparing these bariatric procedures over a time span of 10-20 years, RYGB showed
excellent short-term results and acceptable long-term results on weight loss, comorbidities 
[108, 109] and HRQL [110].  Even though RYGB seems to produce good results, 
postoperative complications occur in approximately 10% of cases [111]. The postoperative 
complications include deep venous thrombosis, anastomotic leaks, internal hernias, 
gastrointestinal bleeding, ulcers in the bypassed segments, torsion or volvulus of the roux 
limb, closed loop obstruction, stomal stenosis, wound complications, staple-line disruption, 
and gallstone formation following rapid weight loss [111]. Bypassing of the stomach and 
duodenum impairs the absorption of iron, calcium, thiamine and vitamin B12 [112, 113].
Other complications may also occur, such as vomiting, eructation, belching, diarrhoea, 
steathorrhoea, postprandial hypoglycaemia and dumping syndrome [114].
The dumping syndrome gives symptoms such as dizziness, nausea and headaches when
glucose rich food is digested. These symptoms may occur very quickly. When eating fat rich 
food, bariatric patients are also at risk of steathorrhoea – troublesome acute fat diarrhoea. 
These side effects may also have an educative affect, with patients learning to avoid 
overconsumption as well as foods rich in glucose and fat. 
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1.4.2 Lifestyle intervention
Lifestyle intervention in overweight or obesity is a general term describing methods, therapies 
or treatments aiming to induce weight loss, health benefits and improvement of quality of life 
through an alteration of the individuals’ behaviour in everyday life. Lifestyle intervention is a 
generic term and refers to different sorts of diets, training programs, coaching, counselling
and psychological interventions. These may be individual or group based arrangements, be 
health professional led or not, and combine different methods. Lifestyle intervention programs 
can be carried out via the internet, in public, private or commercial facilities, in professional 
out-patient facilities or as a part of complex in-patient treatment programs. 
A comprehensive lifestyle modification programme is recommended as a first step towards
reaching weight loss goals [1]. Such comprehensive lifestyle modification programs usually 
consist of three elements; dietary intervention, physical activity and behavioural intervention
[115]. Such comprehensive programs in obesity management are often termed intensive 
lifestyle interventions (ILI).
Dietary intervention
Reducing energy intake is an important aspect of weight reduction. This can be achieved by 
reducing the intake of certain macronutrients (protein, carbohydrate and/or fat), and gives rise 
to a variety of diets. Fat is the most energy dense of macronutrients, and low fat diets are 
often combined with a proportional increase of whole grain, fruit and vegetables to help obese 
and overweight individuals lose weight [116].
Diets aimed at changing the amount (and type) of carbohydrates are popular. The low 
glycaemic diets are based on how quickly food containing carbohydrates raises blood-glucose 
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levels. Different foods have varying effects on blood sugar levels, with low glycaemic diets 
advocating food with slow absorption carbohydrates, thereby balancing blood sugar levels 
and providing a higher degree of satiety. Another type of low carbohydrate diets are the 
ketogenic diets (high-fat, adequate to high-protein, very-low-carbohydrate). Carbohydrates 
contained in food are converted into glucose and then fuel body cells. If very little 
carbohydrate is digested, the liver converts fat into fatty acids and ketone bodies. The ketone 
bodies pass into body cells and replace glucose as an energy source. In a randomised study,
79 obese patients with type 2 diabetes were given either a low-fat diet or a low glycaemic diet 
for 40 weeks. There were no significantly different weight losses at 20 or 40 weeks, but 
patients with a low glycaemic diet had significantly greater improvements in glycosylated 
haemoglobin (HbA1c), indicating an improvement in their diabetic condition [117]. In a large 
scale trial 811 participants [mean (SD) age 51 (9) years, BMI 33 (4) kg/m2, 64% females] 
were randomised to one of four diets with different macronutrient composition (fat, protein, 
carbohydrates: 20, 15, and 65%; 20, 25, and 55%; 40, 15, and 45%; and 40, 25, and 35%). All
the diets were calibrated such as to have a daily 750 kcal deficit.  After 2 years the authors 
found no significant difference in weight loss between groups, and concluded that reduced-
calorie diets result in clinically meaningful weight loss regardless of which macronutrients 
they emphasise [118].
Low calorie diets and very low calorie diets are commercially popular and produce rapid 
weight loss. Critics of low calorie diets point to poor adherence in the long run and secondary 
weight regain. However, several studies indicate that greater initial weight loss improves 
long-term weight loss [119-124]. In a recent American study of 1685 multi-ethnic obese 
participants, weight loss at 6 months was found to be a consistent predictor of weight loss 
after 36 months across gender and ethnic groups [123]. The same was reported in a Swedish 
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study of 247 participants undergoing a two-step weight loss program lasting for 8–10 months. 
The strongest factor for predicting weight loss in the Step II treatment was Step I weight loss. 
Each 1 kg weight loss in Step I predicted 13% of the variation in Step II weight loss [119].
The randomised multi-centre Look Ahead-study found that the larger a participant’s weight 
ORVVZDVDIWHUWKHILUVW\HDUWKHODUJHUWKHLUORVVDW\HDU7KHRGGVRIDFKLHYLQJDORVV 10% 
of baseline weight at year 4 were 9.8 (95% CI: 6.99–13.74) times greater for participants who 
ORVW 10% at year 1 compared to participants who lost <5% at year 1, and 2.0 (95% CI: 1.41–
2.96) times greater for participants who had lost 5.0–9.9% at year 1 compared with those who 
lost < 5% at year 1 [124].
A Finnish study examined obese hospital outpatients undergoing a 10 week low calorie diet 
followed by 4 month group sessions, assessing the development of HRQL changes after years 
1 and 2. The 100 patients [mean (SD) age 48 (11) years, BMI 43 (6) kg/m2, 66% women]
finishing treatment lost 12.5% of baseline weight and improved all HRQL scales markedly. 
After 2 years mean weight regain was two thirds of the lost weight and HRQL improvements 
were maintained only in the psychosocial and physical functioning domains. The subgroup 
ZLWKPDLQWDLQHGZHLJKWORVVmaintained a cluster of positive HRQL improvements 
relative to baseline [125].
Physical activity
Physical activity (PA) is considered an integral part of weight management. In 2001 the 
American College of Sports Medicine (ACSM) recommended [126] a minimum of 150 
minutes per week of moderate-intensity PA for overweight and obese adults to lose weight.
Obese adults should progressively increase this exercise goal. In 2009 the ACSM pointed out
that recent evidence supported this recommendation but also indicated more PA to be 
26 
 
necessary [127].  The ACSM found that moderate-intensity PA (between 150 and 250 minutes 
per week) provided only modest weight loss, and that a greater amount of PA (> 250 minutes 
per week) was associated with a clinically significant weight loss. In a two year randomised 
trial 201 overweight and obese women [mean (SD) BMI 33 (4) kg/m2, age 38 (6) years] were 
assigned to 1 of 4 groups based on physical activity energy expenditure (1000 vs. 2000
kilocalories per week) and intensity (moderate vs. vigorous) [128]. Energy expenditure was 
converted to minutes per week based on the average body weight of participants and weekly 
goals were expressed in minutes per week. Participants were encouraged to spread the 
exercise over 5 days per week and to exercise for a minimum of 10 minutes each time. 
Intensity was prescribed as percentage of age-predicted maximal heart rate (moderate, 50-
65%; vigorous, 70-85%) and rating of perceived exertion (moderate, 10-12; vigorous, 13-15). 
After 2 years there were no significant differences between groups and all groups regained 
weight between years 1 and 2 [128].
The ACSM positional statement suggests that PA on its own is of limited benefit in terms of
inducing weight loss [115]. However, weight loss is not the only end point of PA. There is no
doubt that regular PA contributes to the prevention of cardiovascular disease, diabetes, cancer, 
hypertension, obesity, depression and osteoporosis, and is moreover associated with a reduced 
risk of premature death [129] as well as improvement of HRQL [130, 131].
Behaviour intervention
Traditionally, behaviour intervention in obesity management has been based on the 
assumption that behaviours  regulating body weight are learned, and thus can be relearned or 
modified [132]. Today, most researchers believe that body weight is also affected by factors 
other than behaviour. These include genetic, metabolic and endocrine influences [133].
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During the last two decades, cognitive elements have been added to the behaviorual 
component of obesity management. The underlying assumption is that thoughts (cognitions) 
directly affect feelings and behaviours [133] and that negative feelings are associated with 
negative outcomes.
Behaviour intervention is goal directed, process oriented and advocates small rather than large 
changes [133, 134] and consists of some common components; self-monitoring (food and 
activity records), eating stimulus control, nutrition education, slowing eating, physical 
activity, problem solving, and cognitive restructuring [132, 133].
A review of 9 meta-analyses and systematic reviews comprising 198 trials with > 23,000 
participants on lifestyle interventions for obesity (between 1999 and 2009) found little 
evidence to indicate that any one component (ie. diet, PA, behavioural/cognitive) was more 
effective than any other [135]. However, there seemed to be an additive effect when 
combining the components in the treatment of obesity.
Intensive behavioural intervention in specialized weight loss centres can be a safe and 
effective treatment option for severely obese individuals. In one study [136], 1100 morbidly 
obese patients [mean (SD) BMI 49 (8) kg/m2, age 44 (11) years, 63% women] completed a 
12-week “Core-intervention” class with follow-up until participants reached their weight goal 
and  entered a maintenance phase. The maintenance phase included weekly meetings and 
telephone calls, record keeping, restricted energy intake and physical activity. The mean (SE)
weight loss was 25 (.01) % of initial weight after mean (SE) 39 (1) weeks. Weight loss after 
72 weeks was on average 23 kg (59% maintained weight loss). 24% (n=268) had a mean 
weight loss of 40% in an average of 57 weeks [136].
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Not only may the content of an ILI have an impact on outcomes, but also its structure. Martins 
et al. [137] studied the association between the structure of a 2 year residential intermittent 
ILI program (totaling five stays) for morbidly obese, weight loss and cardiorespiratory fitness. 
This retrospective follow up study [n = 179, mean (SD) BMI 44 (6) kg/m2] compared 81 
participants with a first stay of 8 weeks (total length of stays = 18 weeks, group A) with 98 
participants with a first stay of 2 weeks (total length of stays = 12 weeks, group B). After 2 
years, the completers in group A (n = 52) had a mean (SD) weight loss of 13 (10) % versus 
group B (n = 65) of 6 (9) % (p < .001). The same pattern was observed when measuring 
changes in cardiovascular fitness. There was a larger improvement in peak oxygen uptake at 
both 1 and 2 years in group A compared with group B [7.8 vs. 3.6 ml/kg/min (p < 0.01) and 
5.6 vs. 2.5 ml/kg/min, (p < 0.01), respectively] [137]. Another Norwegian study  [138] found 
that morbidly obese subjects following a 10-14 week ILI at a rehabilitation centre lost a mean 
(SD) of 15 (9)% of baseline weight at 12 months. Neither study examined changes of HRQL.
Other studies of ILI have shown promising HRQL results. Gjevestad et al. [139] showed that 
a 1 year outpatient ILI at a public tertiary care centre was associated with significant mean 
(95% CI) weight loss of 10 (9-12)% and improved physical HRQL of mean (95% CI) 7 (4-9) 
points (ES = .54), mental HRQL of 4 (1-7) points (ES = .18) and emotional HRQL of 18 (13-
23) (ES = .77).  A moderate outpatient lifestyle intervention program at a public secondary 
care centre was associated with only limited beneficial effects on weight loss and HRQL. 
Few studies have addressed the comparative effects of bariatric surgery and lifestyle 
intervention on HRQL. The SOS-study compared patients undergoing various bariatric 
procedures with patients undergoing conventional weight-loss treatment [110]. Notably, 
treatment for the conventionally treated patients was not standardised and treatment regimens 
varied according to local practice. After 10 years, the study showed that patients who chose 
surgery lost about 15 times more weight than non-surgically treated patients, mean (SD) loss 
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of 19.7 (15.8) kg vs. 1.3 (13.8) kg. HRQL improved to a significantly greater extent in the 
surgery group (compared to the non-surgically treated group) in the domains of current health 
perception, social interaction, psychosocial functioning and depression. No significant
between group differences were found for overall mood and anxiety. This effect was mainly 
explained by weight loss. Notably, the study did not predefine the lifestyle intervention for the 
non-surgical groups, which makes comparison between bariatric surgery and lifestyle 
programs difficult. In general, there is limited comparable evidence regarding HRQL 
following RYGB and specific predefined comprehensive and multidisciplinary lifestyle 
intervention. 
In addition, most studies of HRQL in morbid obesity have focused on the physical and mental 
aspects, applying generic instruments of HRQL measurement. The development of obesity-
specific HRQL instruments enables additional analyses of the emotional and symptomatic 
dimensions. Furthermore, only a few studies of morbidly obese HRQL have calculated the 
clinical relevance of HRQL-change after treatment.
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2. Aims of the thesis
The aim of this thesis was to explore and investigate three research questions;
1. Is the HRQL of treatment-seeking morbidly obese subjects associated with 
employment status? 
2. Is bariatric surgery more effective than intensive lifestyle intervention in terms of
improving HRQL?  
3. Does the structural validity of the SF-36 hold in a population of morbidly obese 
treatment seeking subjects?
These research questions led to the following hypotheses:
Paper I: 
Employment is associated with higher HRQL in treatment seeking morbidly obese persons.
Paper II:
Bariatric surgery provides greater improvements in HRQL than intensive lifestyle 
intervention.
Paper III:
The structural validity of the SF-36 is high in a population of morbidly obese treatment 
seeking patients.
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3. Material and methods
3.1 Participants and study design
Two of the studies (paper I and paper II) underlying this thesis are based on data from the 
non-randomised pragmatic clinical MOBIL-study (Morbid Obesity treatment, Bariatric 
surgery versus Intense Lifestyle intervention, Clinical Trials.gov number NCT00273104),
which was designed to compare the efficacy of bariatric surgery and intensive lifestyle 
intervention on various comorbidities, eating behaviour and HRQL. All patients were 
morbidly obese and referred from secondary health care clinics to the Morbid Obesity Centre 
at Vestfold Hospital Trust, located in Tønsberg, Norway. 
One cross-sectional validation study (paper III) is based on data from Evjeklinikken AS, a 
rehabilitation centre specialising in intensive lifestyle intervention (ILI) in morbid obesity. 
Evjeklinikken AS is located in Evje, Norway. Patients were referred to the rehabilitation 
centre from both the Morbid Obesity Centre and from secondary health care clinics under the 
South Eastern Regional Health Authority in Norway.
Table 1. Study design, population and sample size of the three studies.
Paper Study design Population Sample size
I Pragmatic non-randomised clinical 
trial/cross-sectional analysis 
(baseline data)
Morbidly obese  treatment 
seeking patients
143
II Pragmatic non-randomised
clinical trial
Morbidly obese  treatment 
seeking patients
139
III Cross-sectional validation Morbidly obese  treatment 
seeking patients
475
All studies were approved by the Regional Committees for Medical and Health Research 
Ethics and performed in accordance with the Helsinki protocol.
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3.1.1 The MOBIL-study (paper I and II)
Paper I and II included patients from the MOBIL-study. The flow of patients is shown in 
figure 2.
Figure 2. Flow of patients (paper I and II)
Between December 2005 and May 2006 a total of 228 first time patients attending the Morbid 
Obesity Centre were pre-screened for participation in the study. A total of 181 patients 
satisfied the inclusion criteria for bariatric surgery and desired either RYGB surgery or ILI.
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Finally, 146 patients were accepted for either RYGB (n = 80) or ILI (n = 66). Three patients 
did not fill out HRQL-questionnaires [either not at all (n = 2) or with > 90% missing items 
(n = 1)], leaving data from 143 patients to be included in paper I.  One year follow up was
completed by June 2009. A total of 139 patients (95%) completed the study and data from 
these completers is explored in paper II. 
All surgical procedures were performed at the Morbid Obesity Centre at Vestfold Hospital 
Trust, and the majority (59/63) of patients in the lifestyle group were referred to a 
rehabilitation centre specialising in the care of morbidly obese patients (Evjeklinikken AS).
3.1.2 Cross-sectional validation study (paper III)
Paper III was based on data collected at Evjeklinikken AS. In order to reduce potential 
selection bias, all patients with morbid obesity (n = 537) admitted to the rehabilitation centre
between May 2005 and September 2009 were sent the SF-36 prior to their first admission. All 
subjects (n = 537) were non-immigrants of Caucasian ethnicity. Of these, 62 (11%) patients 
had more than 60% missing item values, leaving 475 (89%) patients eligible for further 
statistical analysis. 
3.2 Interventions 
Two major interventions were applied; Roux-Y-Gastric Bypass (RYGB) and intensive 
lifestyle intervention (ILI).
3.2.1 Surgical intervention
Patients in the RYGB group completed a low-calorie diet (3.3–3.8 MJ/day)  3–6 weeks before 
surgery [140]. Laparoscopic RYGB was performed in 74 of the 76 surgically treated patients. 
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The gastric pouch was about 25 ml, while the median (range) of alimentary limb was 120
(80–250) cm; biliopancreatic limb 100 (50–170) cm; and common channel, variable length. 
The bariatric surgeons tended to choose longer limbs in the heaviest patients. After surgery, a 
standardised regimen of dietary supplements [112] and a proton pump inhibitor were 
prescribed to all patients. Patients with a high risk of venous embolism were prescribed low-
molecular weight heparin. During follow-up, patients allocated to surgery were examined by a 
bariatric surgeon 6 weeks post-surgery, while groups of patients were seen by a registered 
dietician quarterly. To optimise the result of the procedure patients were encouraged, both 
before and after the surgery, to normalise their eating behaviour and to increase their physical 
activity level [140].
3.2.2 Lifestyle intervention
The lifestyle intervention is best described as a partly residential multidisciplinary intensive 
lifestyle-intervention program. The treatment goal for individual participants was to lose 
approximately 10% of their baseline body weight. Each patient was encouraged to increase 
their physical activity and to normalise eating habits. The programme intended to increase the 
patients’ self-efficacy in dealing with their weight problem, as well to improve their self-
esteem. 
The 1-year ILI comprised of four stays at a rehabilitation centre – three 5-day stays in weeks 
1, 26, and 51, and a four-week stay from weeks 13–17 (figure 3). 
Figure 3. Structure of stays at the rehabilitation centre
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The daily schedule was divided between organised daily physical activity of varying intensity 
(3–4 hours); walks, swimming, bicycling, gymnastics, yoga, and football. The daily schedule 
also included various individual and group based psychosocially oriented interventions 
combined with a motivational approach (3–4 hours), and moreover included consultations 
with a medical doctor, registered dieticians, physiotherapists and mental health trained nurses. 
No special diet or weight-loss drugs were prescribed, but patients were encouraged to follow 
the guidelines of the Norwegian National Council of Nutrition [141], which recommends that 
the daily intake of protein, fat, carbohydrate and alcohol should account respectively for 10–
20, <30, 50–60, and <5% of energy consumed. In addition, the patients were asked to reduce 
their daily total energy intake, but not using calorie counting. Nutritional advices were 
conveyed to the patients through individual consultations and group sessions with registered 
dieticians. Outside their stays at the rehabilitation centre, patients were contacted by phone 
once every second week and were also encouraged to consult their GP for weight 
measurement and follow-up every four weeks. They were also encouraged to self-monitor 
eating habits and physical activities on a daily basis in a prefabricated paper based diary. In
the diary, patients were to mark what kind of meals they had eaten, approximately how many 
steps they had taken, their main daily activities and their “food temptations”. They were also 
encouraged to write a few words describing their emotions that day. The patients were also 
instructed to bring the diary to their GP.
3.3 Variables
3.3.1 Outcome variables
In sum, three HRQL instruments (SF-36, OWLQOL and WRSM) constitute five different 
measurements of HRQL; physical HRQL (SF-36 physical component score), mental HRQL
(SF-36 mental component score), emotional HRQL (OWLQOL total score), number of 
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obesity symptoms (WRSM symptom count), and distress of obesity symptoms (WRSM 
symptom distress core). The primary outcome variables in papers I-III were the scores on 
HRQL-instruments measuring physical HRQL, mental HRQL, emotional HRQL (paper I), 
physical HRQL, mental HRQL, emotional HRQL, number of obesity symptoms, and 
symptom distress (paper II). In paper III, only SF-36 was under study.
3.3.2 Explanatory variables
All participants underwent a medical examination by a physician during their first 
consultation. Demographic data, socioeconomic history and medical history were recorded. 
Weight and height were measured with patients wearing light clothing and no shoes. BMI was 
calculated as weight in kilograms divided by the square of the height in metres. Blood 
pressure was measured three times after at least 5 minutes rest, at the right or left brachial 
artery, with the patient in a sitting position. The average of the second and third measurements 
was registered. Hypertension was confirmed if either systolic blood pressure was greater than 
140 mm Hg, if diastolic blood pressure was greater than 90 mm Hg, or if the patient received 
antihypertensive drugs. All patients underwent one overnight sleep registration with a 
portable monitor, the Embletta™ system; which has both high sensitivity and specificity when 
compared to the “gold standard” overnight polysomnography used to identify obstructive 
sleep apnoea (OSA) [105]. OSA was diagnosed for patients with moderate to severe sleep 
apnoea [apnoea–hypopnea index (AHI)  15 events per hour] as these patients are more likely 
to have symptoms than those with mild OSA. Type 2 diabetes was diagnosed in patients 
treated either with glucose-ORZHULQJGUXJVRUZLWKDIDVWLQJJOXFRVH 7.0 mmol/l and/or a 2-
hour JOXFRVH 11.1 mmol/l after the ingestion of a 75-g anhydrous glucose solution [106]. In 
addition, all patients completed a questionnaire about their diet and physical activity [107]. 
Patients were  categorised as having a sedentary lifestyle if they had no (less than 10 min a 
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week) aerobic moderate or vigorous activity based on their answer to the following question: 
“Do you perform any physical activity and exercise making you a little short of breath (more 
than 10 min a week bicycling, swimming, walking, skiing, dancing, or golfing)?”
3.3.3 Assessment of change scores (paper II)
The two interventions were expected to affect HRQL scores. These HRQL changes might be 
assessed statistically and statistical significance may be calculated as a p-value. However, 
statistical significance does not always imply clinical relevance and for many clinicians, the 
unfamiliarity of the different HRQL scales may cause uncertainty as to how to interpret the 
results. Calculating effect size (ES) by Cohen's d is one way to assess the clinical relevance of 
change scores on a HRQL-instrument pre and post treatment [142-144]. Cohen´s d is 
understood as the standardised difference between two means [143] and is defined by Jacob
Cohen [145] as the average change from pre-test to post-test divided by the standard deviation 
at baseline. Norman et al. compared the responsiveness of Cohen’s d against 9 other indices 
(standardized effect size, normalized ratio, responsiveness statistic, Guyatt responsiveness, 
standardized response mean, reliable change index, unpaired T-test, and paired T-test) on 
observed change scores on measure of health status (n = 50). The authors concluded that
Cohen’s d is the most appropriate measure, as it provides unique information and captures an 
important relation between treatment effect and variability in response. The authors 
recommend that future analysis of responsiveness should be restricted to Cohen’s d in order to
ensure interpretability and comparability with treatment effects in other domains.
This also implies that Cohen’s d is applicable on different scales in the same intervention. The 
standardized changes can be compared using the same unit of measure (SD), despite the 
scales having different ranges of values [143-145]. In addition, Cohen’s d provides a general 
set of thresholds or benchmarks as to the impact of an intervention, with a Cohens d from .20–
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.49 to be considered small, .50–.79 as moderate, and greater than .80 as large [143, 144].
Cohen’s d is from hereafter referred to as effect size (ES).
3.4 Statistical methods
Data are presented as mean (SD) or n (%) unless otherwise stated. Skewed data were 
transformed to approximate normality using natural logarithms. To assess the reliability of the 
HRQL scales we calculated Cronbach’s alpha coefficients. 
Within-group analyses were performed using paired samples t-test. Between-group 
comparisons at baseline were analysed using independent samples t-test for continuous 
YDULDEOHVDQGȤ2 or Fisher’s exact test for categorical variables. Two-tailed P values are 
reported; with p < .05 was considered to be statistically significant. 
In paper I we also performed three multiple linear regression analyses, with physical, mental 
and emotional HRQL as dependent variables. Ten predefined explanatory variables were 
included in each model. In examining the variation of inflation factors in the models we found 
no consequential multicollinearity between the independent variables. The probability–
probability plot between expected and observed cumulative distribution was considered 
acceptable. Semi-partial (part) correlation coefficients were squared in order to calculate the 
percentage of total variance in the dependent variable explained by a given independent 
variable.
In paper II, after applying Little’s test of randomness for missing data, missing values (SF-36:
23.5%, OWLQOL: 24.5%, WRSM: 23.7%) were imputed using multiple imputation. The 
imputation model consisted of the following predictor and imputation variables: five HRQL-
scores (physical, mental, and emotional dimensions and number of obesity symptoms and 
symptom distress), physical activity at baseline and 1 year, and age of onset of obesity.
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Treatment, gender, age, baseline BMI, marital status, employment and education were 
included as predictor variables only. Through a fully conditional specification model, 
applying linear regression as the prediction method for scale variables and two-way 
interactions for categorical variables, we generated 20 complete datasets for each of the 
HRQL-scores with 10 iterations per dataset. The statistical analyses were performed within
each complete dataset, and thereafter the multiple analyses results were combined to achieve 
single estimates. The combined estimates are presented.
Within groups ES was calculated as the mean HRQL change score between 1 year and 
baseline divided by the standard deviation of the baseline HRQL. Between groups ES was 
calculated as the difference in mean HRQL change score between groups at 1 year divided by 
the standard deviation of baseline HRQL of the sample [143, 144].
In order to reduce problems of regression towards the mean [146, 147], we applied five one-
way analyses of covariance (ANCOVA) to compare the effect of RYGB and ILI on the five 
dimensions of HRQL between groups. Age at baseline, age at the onset of obesity, BMI at 
baseline, physical activity at baseline, and baseline HRQL-scores were used as covariates in 
each of the five analyses [148]. Assessments of normality, linearity, homogeneity of variance 
and regression slopes were conducted to ensure assumptions for the ANCOVA. The 
unadjusted changes from baseline in the RYGB group and ILI group together with the 
adjusted between group differences (95% CI) are reported. To account for the percent 
H[SODLQHGYDULDQFHLQWKHGHSHQGHQWVFDOFXODWLRQVRISDUWLDOHWDVTXDUHGȘS2) were 
performed. To test the effect of weight reduction (instead of treatment choice) on HRQL 
multiple linear regression analyses were conducted with each of the 12 months HRQL 
changes (physical, mental, and emotional dimensions, number of obesity symptoms, and 
symptom distress) as dependents, and with the following as independents: gender, age at 
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baseline, age at the onset of obesity, BMI at baseline, physical activity at baseline, and weight 
change as percent of baseline weight. 
In paper III we examined the component structure of the SF-36 and applied a PCA with an 
oblique (promax) rotation [149, 150]. The Kaiser-Meyer-Olkin measure and Bartlett’s test of 
sphericity were computed to determine whether the data in this sample were suitable for PCA. 
How many factors to retain is a critical component of exploratory factor analysis. Following 
Kaiser’s criterion, eigenvalues of 1.0 were chosen to ensure that the extracted components 
accounted for a reasonably large proportion of the total variance [150]. Methodological 
research has shown that the Kaiser’s criterion may include too many components [149, 151].
A parallel analysis [149] was conducted to affirm the extraction. Parallel analysis involves 
comparing the eigenvalues from the actual sample with those obtained from a randomly 
assigned dataset. A correlation matrix is calculated from the randomly generated dataset, and 
the eigenvalues of the correlation matrix are computed. Components corresponding to the 
initial eigenvalues that are greater than the parallel average random eigenvalues should be 
retained. An item was considered to be loaded on a component if coefficients were 0.32 or 
larger [150]. To assess the model fit, we applied confirmatory factor analyses (CFA) as 
structural equation modelling. Two tests of goodness of fit were used to evaluate the models, 
the Comparative Fit Index (CFI) and the Root Mean Squared Error of Approximation 
(RMSEA). A CFI > 0.90 indicates that the model has a good fit to the data.  RMSEA < 0.08 
indicates a good fit to the data, while values > 0.10 suggest that the model fit is unsatisfactory 
[150].
The statistical analyses in the three papers were conducted using SPSS Statistics v. 17.0-18.0
(SPSS Inc., Chicago, IL, USA/ IBM Corp., Armonk, NY, USA), PRELIS v. 8.8 (SSI Inc., 
Lincolnwood, IL, USA) for principal component analyses, Windows MonteCarlo PCA for 
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parallel analysis, and AMOS v. 18.0 (IBM Corp., Armonk, NY, USA) for confirmatory factor 
analysis.
4. Results
4.1 Paper I
Our study demonstrated that in morbidly obese patients allocated to either surgical treatment 
or lifestyle intervention, controlling for age, gender, current BMI, obesity history, marital 
status, and comorbidities, employment was independently associated with both the physical 
and mental aspects of HRQL as measured with the SF-36. Conversely, employment was not 
associated with the emotional aspects of HRQL as measured with the OWLQOL (table 3).
Table 3. Predictors of HRQL in 143 morbidly obese patients (paper I)
QOL dimension Physical, R² =0.36, Coeff.
Mental, R² =0.17, 
Coeff
Emotional, R² =0.26, 
Coeff.
Gender 0.13 0.15 0.51***
Age -0.22* 0.07 0.07
BMI -0.09 0.13 -0.15
Marital status -0.09 -0.02 0.05
Education -0.07 -0.06 0.01
Employment 0.43*** 0.33** 0.07
Hypertension 0.03 0.01 0.16
OSA -0.09 -0.03 0.06
Type 2 diabetes -0.14 -0.11 -0.04
Seeking surgery 0.26** 0.12 0.13
Standardized (beta) regression coefficient values are given. Linear regression; * p < 0.05, **p < 0.01, 
***p < 0.001
Squared part correlations showed that employment explained 16% of the variation in the 
physical HRQL and 9% of the variation in the mental HRQL. Gender explained 22% of the 
variation in the emotional HRQL.
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4.2 Paper II
We found that the effectiveness of RYGB was greater compared to ILI in improving HRQL
after 1 year. Within the RYGB group all HRQL dimensions showed large improvements. 
Within the ILI group, all HRQL changes were small to moderate.
The inter-item analyses showed Cronbach’s alpha coefficients > .80, indicating that 
intercorrelations among the items was high and thus that there is a high reliability for all of 
the HRQL-scales (physical, mental, and emotional dimensions, number of symptoms, and 
symptom distress).
Compared to the ILI group, the patients in the RYGB group had a higher BMI (ES = .49), 
were younger (ES = .36), had earlier onset of obesity (ES = .47), and had lower physical 
(ES = .50) and emotional HRQL (ES = .42). All patients in the RYGB group lost more than 
15% of their baseline weight. In the ILI group 62% lost  5% and 38% lost  10% of their 
baseline weight. 
Adjusted between group analyses, controlling for age at baseline, age at the onset of obesity, 
BMI at baseline, physical activity at baseline, and baseline HRQL-scores, showed that the 
RYGB group had statistically significant higher adjusted mean improvement in all HRQL-
measurements, especially emotional HRQL (table 4%DVHGRQFDOFXODWLRQVRIȘS2, type of 
treatment predicted 19.7% of the variance (ES = .83) in the physical dimension change score, 
9.8% (ES = .50) in the mental dimension change score, 22.6% (ES = 1.06) in the emotional 
dimension change score, 7.7% (ES = .56) in the number of symptoms, and 8.1% (ES = .37) in 
the symptom distress change score. 
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Table 4. One way between-groups analysis of variance on five dimensions of HRQL in 
morbidly obese patients undergoing either RYGB or ILI. (paper II)
Changes from baseline
Adjusted between 
group difference, 
mean (95% CI)
RYGB 
(n=76)
ILI 
(n=63) P ES
Physical dimensiona 16.8   (9.7) 4.9   (9.4) 8.6 (4.6,12.6) <.001 .83
Mental dimensiona 9.6   (9.1) 3.5   (8.9) 5.4 (1.5,9.3) .007 .50
Emotional dimensionb 42.7 (25.5) 15.7 (21.7) 25.2 (15.0,35.4) <.001 1.06
Number of obesity symptomsc -5.3   (4.6) -2.9   (4.7) -2.3 (-4.5,-.6) .012 .56
Symptom distressd -25.2 (20.7) -14.3 (16.5) -8.7 (-15.4,-1.8) .013 .37
Adjustments were made for age at the onset of obesity and baseline values of age, BMI, physical activity level, 
and HRQL. (a) SF-36 (scale 0-100). (b) OWLQOL (scale 0-102). (c) WRSM (scale 0-20). (d) WRSM (scale 0-
120). Statistical significance (P) and effect size (ES) are reported.
Unadjusted within-group analyses showed that both groups reported improvements in all five 
HRQL-measurements (figure 4 and 5). 
Figure 4.  Mean scores on five HRQL-scales at baseline and 1 year in morbidly obese patients 
who underwent RYGB (n=76) (paper II).
(a, b) SF-36 (scale 0-100). (c) OWLQOL (scale 0-102). (d) WRSM (scale 0-20). (e) WRSM (scale 0-120).
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Figure 5. Mean scores on five HRQL-scales at baseline and 1 year in morbidly obese patients 
who underwent a partly residential intensive lifestyle intervention program (n=63) (paper II).
(a, b) SF-36 (scale 0-100). (c) OWLQOL (scale 0-102). (d) WRSM (scale 0-20). (e) WRSM (scale 0-120).
Compared to the ILI group, the RYGB group showed greater improvement in problems such 
as reduced physical stamina, joint pain, snoring, sleep problems, skin irritation, water 
retention, and foot problems. Only the improvements of physical stamina and joint pain 
showed large effect sizes between groups. On the other hand, the RYGB group reported 
higher sensitivity to coldness, and this difference was considered large.
The multiple linear regression analyses of weight reduction (instead of treatment choice) on 
HRQL showed a standardized (beta) coefficient of -.430 (p < .001) on the physical dimension, 
-.288 (p = .004) on the mental dimension, -.432 (p < .001) on the emotional dimension, .287 
(p = .008) on number of symptoms, and .274 (p = .009) on reduction of symptom pressure. 
45 
 
4.3 Paper III
The summary scales of the SF-36 had satisfactory construct validity in treatment seeking 
morbid obese patients. The construct validity of the subscale scores was, however, weak.
Table 5 shows the items of the SF-36 loaded on 6 components when tested in a sample of 475 
Norwegian morbidly obese patients seeking intensive lifestyle intervention. 
When forcing the PCA into a 2-component extraction, the items loaded into a physically and a 
mentally oriented domain (table 6). 
The analyses of model fit show an acceptable fit for the 6-component model (RMSEA = .08, 
CFI = .81) (table 5) and an unacceptable fit for the original 8-component model 
(RMSEA = .13, CFI = .47) (data not shown). The 2-component model has acceptable fit, both 
as a second order model (RMSEA = .08, CFI = .84) (data not shown) and as a single item 
model (RMSEA = .07, CFI = .88) (table 6). 
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Table 5. Rotated structure in a 6-component PCA, oblique (promax) rotation; presenting item 
loads of the SF-36 on components 1–LWHPVZLWKORDGLQJVLQEROGIRUPRUELGO\
obese patients (n = 475) (paper III)
PF=physical functioning, RP=role physical, BP=bodily pain, GH=general health,  VT=vitality, RE=role 
emotional, SF=social functioning, MH=mental health
              
      Components
  Items Item text
Sub-
scale 1 2 3 4 5 6
  sf3a "Health limits vigorous activities"
PF
.64 -.10 .00 -.07 -.12 -.04
  sf3b "Health limits moderate activities" .58 .26 -.10 .05 .07 -.02
  sf3c "Health limits lifting and carrying groceries" .06 .49 -.02 .22 .06 -.01
  sf3d "Health limits climbing several flights of stairs" .76 .18 -.02 -.15 -.06 -.03
  sf3e "Health limits climbing one flight of stairs" .40 .55 -.05 -.13 .04 -.01
  sf3f "Health limits bending, kneeling or stooping" .76 .08 -.05 -.01 -.09 -.09
  sf3g "Health limits walking more than a mile" .62 .38 .05 -.11 -.12 -.02
  sf3h "Health limits walking several hundred yards" .20 .80 .06 -.05 -.03 .05
  sf3i "Health limits walking one hundred yards " -.10 .90 .07 .02 .00 .05
  sf3j "Health limits bathing or dressing yourself " .18 .39 -.14 .05 .10 .05
  sf4a "Due to physical health cut down time on work”
R
P
.25 .14 .13 .26 .04 .06
  sf4b "Due to physical health accomplished less" .45 .00 .21 .13 -.13 .18
  sf4c "Due to physical health limited in work" .53 .00 -.03 .27 .01 -.08
  sf4d "Due to phys. health difficulty perform. work" .61 .02 .03 .15 .01 -.08
  sf7 "Bodily pain"
B
P .07 .01 -.01 .79 -.09 .08
  sf8 "Pain interfered with normal work" .13 -.01 .01 .85 -.01 .00
  sf1 "Self reported health"
G
H
.47 .13 -.04 .09 .17 -.04
  sf11a "Seem to get ill more easily than other people" .18 -.09 .04 .14 .26 -.08
  sf11b "As healthy as anyone I know " .28 -.04 -.02 .16 .21 -.05
  sf11c "Expect my health to get worse" .21 -.05 .00 -.06 .04 .15
  sf11d "Health is excellent" .47 -.12 -.09 .06 .15 .08
  sf9a "Felt full of life"
V
T
.32 -.09 .09 -.09 .07 .26
  sf9e "Have had a lot of energy" .28 -.06 .07 -.01 .12 .40
  sf9g "Felt worn out" -.07 .05 -.09 .10 .15 .79
  sf9i "Felt tired" -.11 .06 .00 -.01 .06 .89
  sf6
"Extent physical health or emotional problems 
interfered with normal social activities"
SF
.02 .04 .03 .03 .80 -.03
  sf10
"Physical health or emotional problems have 
interfered with social activities" .07 .06 .06 .02 .76 -.06
  sf5a "Due to emotional problems cut time on work"
R
E
-.01 .05 .61 .01 .33 -.08
  sf5b "Due to emotional problems accomplished less" -.04 .03 .82 .00 .14 .02
  sf5c "Due to emotional problems work less carefully" .01 .01 .63 .00 .20 -.06
  sf9b "Been very nervous"
M
H
-.16 .09 .07 -.05 .69 .09
  sf9c "Felt so down in dumps" -.07 -.02 -.07 .01 .91 -.03
  sf9d "Felt calm and peaceful" .03 -.02 .12 -.09 .67 .03
  sf9f "Felt downhearted and low" -.10 -.05 -.09 -.04 .86 .13
  sf9h "Been happy" .15 -.14 .09 -.06 .53 .08
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Table 6. Rotated structure in a two-component PCA. Presenting item loads on component 1 
DQG,WHPVZLWKORDGLQJVDUHPDUNHGLQEROGIDFHSDSHU,,,
Composite 
scores
Component
Items Item text 1 2
sf3a "Health limits vigorous activities"
Ph
ys
ic
al
 d
im
en
si
on
.40 -.01
sf3b "Health limits moderate activities" .76 .00
sf3c "Health limits lifting and carrying groceries" .62 -.07
sf3d "Health limits climbing several flights of stairs" .70 -.05
sf3e "Health limits climbing one flight of stairs " .75 -.14
sf3f "Health limits bending, kneeling or stooping" .70 -.07
sf3g "Health limits walking more than a mile" .78 -.14
sf3h "Health limits walking several hundred yards" .82 -.17
sf3i "Health limits walking one hundred yards " .71 -.21
sf3j "Health limits bathing or dressing yourself " .55 -.05
sf4a "Due to physical health cut down time on work” .47 .23
sf4b "Due to physical health accomplished less" .45 .24
sf4c "Due to physical health limited in work" .60 .08
sf4d "Due to phys. health difficulty perform. work" .61 .11
sf7 "Bodily pain" .51 .13
sf8 "Pain interfered with normal work" .57 .21
sf1 "Self reported health" .55 .18
sf11a "Seem to get ill more easily than other people" .14 .32
sf11b "As healthy as anyone I know " .28 .26
sf11c "Expect my health to get worse" .09 .18
sf11d "Health is excellent " .32 .28
sf9a "Felt full of life" .11 .38
sf9e "Have had a lot of energy" .16 .51
sf9g "Felt worn out" .09 .57
sf9i "Felt tired" .01 .57
sf6 "Extent physical health or emotional problems interfered with normal social activities"
M
en
ta
l d
im
en
si
on
.03 .79
sf10 "Physical health or emotional problems have interfered with social activities" .08 .76
sf5a "Due to emotional problems cut time on work" -.01 .67
sf5b "Due to emotional problems accomplished less" -.06 .68
sf5c "Due to emotional problems work less carefully" -.04 .59
sf9b "Been very nervous" -.11 .72
sf9c "Felt so down in dumps" -.10 .82
sf9d "Felt calm and peaceful" -.10 .78
sf9f "Felt downhearted and low " -.17 .86
sf9h "Been happy " -.09 .73
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5. Discussion
5.1 Methodological issues
5.1.1 Study designs, patients and representativity
In all the studies (paper I-III) the subjects were Norwegians of Europoid origin, meaning that 
the results cannot be generalized to other populations.
Paper I and II
The MOBIL study was designed as a pragmatic non-randomised clinical trial aiming to 
compare the effectiveness of RYGB and ILI when performed in tertiary care centres,
specialised in the treatment of morbidly obese patients. The term “pragmatic” is used to 
describe trials designed to help choose between options for care. Its counterpart 
“explanatory” describes trials designed to test causal research hypotheses, eg. that an 
intervention causes a particular biological change [152]. The pragmatic design is considered 
more relevant for clinical work and may guide clinical decisions more directly than studies 
with an explanatory design [152].
When planning the study, RYGB was thought to be more effective than ILI at reducing 
weight and improving co-morbidities [110]. According to Norwegian guidelines, treatment 
seeking morbidly obese subjects should be offered either conservative or surgical therapy 
[153]. We therefore considered it unethical to randomly assign patients to RYGB if they 
qualified for an ILI and vice versa. However, this stance has met criticism. When the sample 
was not randomised, baseline differences may give room for confounders and selection bias, 
thereby obscuring the assessment of effectiveness of the two treatments. Compared to the ILI 
group, the patients in the RYGB group had a higher BMI, were younger, had earlier onset of 
obesity, and had lower physical and emotional HRQL. Expecting possible baseline 
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differences between groups [41, 154], multiple regression analyses were planned and 
performed (both in paper I and paper II) in order to adjust for and minimize the possible 
confounding effect of such differences. 
Paper III
This cross-sectional validation study was based on data collected at a Norwegian 
rehabilitation centre specializing in treating morbidly obese patients. The sample in paper III 
consisted solely of treatment seeking morbidly obese subjects. Morbidly obese persons 
seeking treatment may have greater psychological stress than non-treatment seeking severely 
obese [32]. Consequently, generalizability to the general morbidly obese population may be 
limited. Nevertheless, as the prevalence of morbid obesity has increased dramatically over the 
last decade, it is to be expected that larger numbers of morbidly obese may wish to receive 
treatment, diminishing the potential discrepancy between sample results and population.
Furthermore, morbidly obese choosing lifestyle intervention or bariatric surgery differ in
terms of BMI, age, obesity history and HRQL [41, 154], and as such, the results from the 
validation study presented in paper III cannot directly be generalized to morbidly obese not
seeking bariatric surgery.
5.1.2 Data quality
As described earlier, all anthropometric measurements were performed in a standard manner. 
Some of the explanatory variables (eg. work status, marital status, age at onset of obesity, 
length of education, and physical activity) were registered through interviews by internists, 
nurses and registered dieticians. The accuracy of such information is dependent on the 
patients’ motivation and memory. There is evidence that obese patients tend to overestimate 
physical activity [155, 156]. Such data may then not be as accurate as if energy expenditure 
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was measured by indirect or direct calorimetry or by a number of non-calorimetric techniques 
(predicting energy expenditure by extrapolating from physiological measurements). Patient
registration of HRQL may also be affected by motivation. If a patient was to register his or 
hers HRQL prior to a treatment decision, and in order to be prioritized, the patient would 
perhaps register a worse HRQL score than if treatment had already been decided upon. In the 
studies forming this thesis, registration of HRQL data was performed after study inclusion in
the study. The SF-36 has a 1-week recall and the questions aim to elicit answers related to
HRQL elements as they have been over the last week. The other questionnaires aim to explore
the “current” situation of patients.
5.1.3 Missing data
Missing data is common in HRQL research and is a methodological obstacle since it 
represents a risk of biased estimates, distorted statistical power and invalid conclusions [145].
Missing data in paper II was dealt with by multiple imputations of missing values, whilst in in 
paper I and III with mean imputation. We applied also the full information maximum 
likelihood (FIML) method in paper III.
Multiple imputation is based on a prediction model containing variables theoretically 
associated with the variables with missing values. The missing values are predicted using 
existing values from other variables. We created 20 data sets; even if a smaller number of data 
sets has been suggested as valid [157]. However, as the missing data in the 1 year data set for 
some variables was over 20%, 20 datasets with 10 iterations per dataset were needed to give 
an expected relative efficiency of 98-99% [157-160]. Standard statistical analyses were 
carried out on each imputed data set, producing multiple analyses results. These analyses 
results were then combined to produce one overall (pooled) result [159-161]. Multiple 
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imputation accounts for missing data by restoring not only the natural variability in the 
missing data, but also by incorporating the uncertainty caused by estimating missing data.  
The missing values accounted for in paper II may produce a risk of biased estimates, but when 
handled by multiple imputation, this risk was considerably reduced [161].
Of the 537 patients in paper III, 62 (11%) had more than 60% missing item values, thereby 
reducing the accuracy of multiple imputation techniques [159-161] and leaving 475 (89%) 
patients eligible for further statistical analysis. Missing data in the remaining sample (n=475) 
were handled through mean imputation prior to the PCA. Mean imputation is the replacement 
of a missing observation with the mean of the non-missing observations for that variable. This 
method has been questioned [145] even though it may accurately predict missing data, 
especially when missing values are missing completely at random.  Even though the missing 
values was missing completely at random, mean imputation may, theoretically have affected 
the result of the PCA that rely heavily on the correlation mathematics and variance-covariance 
matrixes. However, in paper III we applied structural equation modelling to perform 
confirmatory analyses. When applying structural equation modelling the FIML method is 
available. This missing imputation method uses the whole dataset and, by using maximum 
likelihood estimation, missing values are calculated and imputed. FIML is considered the gold 
standard for the handling of missing data as it applies a full dataset to calculate the probability 
of the correct values in the missing data [160, 161].  The structural equation modelling results 
corresponded with the results of the PCA, giving support for the accuracy of the mean 
imputation of missing data in the PCA-analyses.
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5.1.4 Other methodological considerations
Assessment of clinical relevance
For many clinicians, the unfamiliarity with the many available HRQL instruments may lead to 
research findings that are difficult to interpret in a clinical setting. To reduce this potential 
problem, other methods for assessing HRQL-changes have been developed and applied [142-
144, 163-166]. The calculation of Cohens d, as performed in paper II, is commonly used. 
There are however alternative distributional approaches [144].
The distributional approach aims to measure the reliability of the change score. A 
recommended method is to calculate the standard error of measurement (SEM). The SEM is 
calculated [144] as the standard deviation of the score multiplied by the square root of 1 
minus the reliability of the scale (eg. Cronbach’s alpha coefficient).
Even though several studies have shown the usefulness in applying SEM calculations, there is 
still no agreement as to how large the SEM-change should be in order to detect a clinical 
relevant change in an individual [166]. Some studies find a close correspondence between a 1 
SEM change and a minimally detectable difference in clinical anchors [167, 168], whilst
others finds such correspondence with larger estimates [169], especially in HRQL-
instruments. A 1 SEM change approximates a 68% confidence interval based on a standard 
normal curve. Norquist et. al. [166] suggest an estimate of 1.96 * SEM, which approximates a
95% confidence interval as a conservative approach to reduce the risk of chance. 
The standard error of difference (Sdiff) [166] between two time points is calculated as the 
square root of the subtraction between the SEM at time 1 and SEM at time 2 [168].  
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We have performed post- hoc calculations of SEM and Sdiff based on the data presented in 
paper II. SEM was calculated at baseline and 1 year on each of the 5 HRQL-dimensions. The 
SEM-values were multiplied with 1.96 to approximate the 95% confidence interval and the 
Sdiff between baseline and 1 year was calculated for each of the HRQL dimensions.
As shown in table 7, the Sdiff indicates that a reliable change in the physical dimension should 
be higher than 12 points. A reliable change on the mental dimension should be higher than 13
points, whilst on the emotional dimension such a change should be higher than 14 points. 
Likewise, the number of symptoms should be reduced by 5 and the symptom distress should 
be reduced by 20 points. 
Table 7. Baseline scores and Cronbach’s alpha coefficients at baseline and one year. Standard 
error of measurement (SEM) and standard error of difference (Sdiff) at 1 year. Morbidly obese 
patients (n=139)
Baseline One year 1.96*SEM 
Mean (SD) Į Mean (SD) Į Baseline One Year Sdiff
Physical dimension 36,1 (10,5) 0,82 47,5 (10,3) 0,81 8,71 8,71 12,31
Mental dimension 41,1 (10,8) 0,81 47,9 (10,1) 0,79 9,28 9,16 13,03
Emotional dimension 35,7 (23,7) 0,95 66,1 (26,5) 0,96 10,39 9,85 14,32
Number of symptoms 11,2 (4,1) 0,82 7,1 (4,8) 0,84 3,42 3,72 5,05
Symptom pressure 40,5 (21,0) 0,86 20,2 (16,6) 0,85 15,18 12,43 19,62
The majority of patients in the RYGB group report reaching clinical relevant results on 
physical HRQL, emotional HRQL and symptom distress (table 8). The majority of patients in 
the ILI group reached clinical relevant results on emotional HRQL only. The improvement of 
the emotional HRQL in the RYGB group was particularly pronounced and 87% of the 
patients in the RYGB group reached clinical relevant results after one year (change score > 14 
points).
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The lifestyle group also reported significant improvements in the emotional dimension of 
HRQL after one year, with 52% reaching clinically relevant results. Only 47% of the patients 
in the RYGB group and 27% of the patients in the ILI group reported > 5 symptoms reduction 
after one year. As with the emotional and physical aspects of HRQL, the mental aspects of 
HRQL also improved in both groups after 12 months, even though only 32% and 14% in the 
RYGB-group and lifestyle-group reached clinical relevance. 
Table 8. Number (%) of patients reaching reliable HRQL change. RYGB (n=76) and ILI 
(n=63).
RYGB ILI
N % n % p-value
Physical HRQL 48 63.2 13 20.6 <.001
Mental HRQL 24 31.6 9 14.3 .005
Emotional HRQL 66 86.8 33 52.4 <.001
Number of symptoms 36 47.4 17 27.0 .027
Symptom distress 46 60.5 21 33.3 .004
Weight loss or treatment choice as explanatory variable (paper II) 
Weight loss and improvement of HRQL are significantly associated [37, 110, 170-176]. When 
performing the multivariate regression analyses (ANCOVA) on the 5 HRQL scales (table 3)
the degree of weight change would normally have been incorporated in the regression model. 
However, weight loss and intervention method were highly correlated (r = .81). The mean 
(SD) 1-year weight loss in the RYGB group was 30 (8) % of initial body weight and 8 (9) %
in the ILI group [140], with all patients in the RYGB group losing more than 15% of their 
EDVHOLQHZHLJKW,QWKH,/,JURXSORVW DQGORVW 10% of their baseline weight. 
If the two highly correlated variables (weight loss and intervention method) were to be 
analysed in the same models, the standard errors of both standardized and unstandardized 
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coefficients would inflate and obscure the interpretation of the analyses [145]. Several 
methods were tested: building indexes (combining treatment and weight loss), centring the 
weight loss variable on its mean, as well as re-specifying the regression model and entering an 
interaction term as the cross product of the two variables. We decided, however, to implement
the most common procedure, that is, the removing of the intercorrelated variable (weight loss) 
from the analyses. Being aware of the strong association between weight loss and increased
HRQL in morbidly obese patients, we ran separate linear multivariate regression analyses 
with weight loss in the multivariate models (instead of treatment). The linear regression 
analyses revealed significant associations between weight reduction in percent of baseline 
weight, when controlling for the effect of gender, age at baseline, age at the onset of obesity, 
BMI at baseline and physical activity at baseline. The analyses showed consistent significant 
associations between weight loss and HRQL change, after controlling for potential covariates.
5.2 Main findings and discussion
5.2.1 The importance of employment
Being employed imparts greater benefits than purely financial stability; it implies also that
important routines are formed in daily life and that human contact and social bonds with 
colleagues are formed. In our study (paper 1) we found that employment was associated with 
increased physical and mental HRQL when compared to unemployed patients. However,   
employees did not report a better emotional HRQL than those who were unemployed. One
possible explanation for this is the phenomenon of stigma [74-86, 96, 177], as was discussed 
earlier in this thesis. Being employed implies socializing with colleagues and conforming to 
the norms of the workplace, but at the same time the norms of society at large still prevail. If 
the strong connections between general anti-fat attitudes, stigma and negative emotional 
HRQL hold water, it is then of no surprise that employment does not have a significant impact 
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on emotional HRQL. Women had a lower emotional HRQL independent of whether they 
were employed or not. This finding is in accordance with a Swedish study [83] reporting that 
severely obese women experienced workplace discrimination to a greater extent than obese 
men and normal weight women.
Physical HRQL was higher in the employed group of morbidly obese than the unemployed 
group. This association was independent of age, gender, obesity history, BMI, sedentary 
lifestyle, marital status, and comorbidities such as hypertension, type 2 diabetes and 
obstructive sleep apnoea. One explanation is that employment itself has a positive effect on 
physical HRQL and that this effect is prominent even when controlling for comorbidities such 
as gender, age, education and marital status. Being employed implies having routine such as 
waking up at regular times, travelling to work,  walking around the workplace, walking up
stairs and so on, thereby strengthening physical functioning and reducing physical role 
limitations.  
The finding of a positive association between work status and HRQL may also be interpreted 
as a “healthy worker effect”. Occupational groups often have fewer illnesses and disabilities 
and they are more likely to be assessed as healthier than the population as a whole, giving rise 
to both selection and confounding bias [178, 179]. There are many possible explanations of 
this “healthy worker effect” but the two main explanations are the “healthy hire effect” and 
“the healthy worker survivor effect”.  The former suggests that the healthiest (unhealthy) 
persons are (not) selected to the workforce. The latter suggests that the most healthy workers 
stay in those very same jobs [179]. It may be hypothesized that morbidly obese patients with 
impaired HRQL also have various levels of disability, and were either not selected into the 
workforce in the first place (“healthy hire effect”) and/or that  patients with low HRQL could 
not retain their positions (“healthy worker survivor effect”) [179].
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In sum, the findings in paper I (as in other studies of employment and HRQL) could be 
influenced by both systematic selection and confounding bias. However, the cross-sectional 
study design does not infer any causal relationship and such interpretations cannot be verified.
5.2.2 Lifestyle interventions
The ILI at the heart of paper II consisted of 4 stays totalling 7 weeks. The patients improved 
their HRQL across all dimensions and especially in terms of emotional HRQL, although the 
average weight loss was moderate (8% of baseline weight). Thus, weight loss may not be the 
only explanation of elevated HRQL scores in the ILI group. It is conceivable that the 
intervention itself contributed to this improvement. The group-based focus and motivational 
approach of the lifestyle programme aimed at increasing self-efficacy, self-esteem and mood 
state. Previous studies seem to support this idea. Programmes focusing on motivationally-
oriented group sessions report as little as 3 kg. weight loss (e.g. from 103 to 100 kg.), but have 
found significant improvements in mood state as measured with validated psychometric 
instruments [180]. In another study of 440 obese patients with coronary artery disease, group 
support was reported to be associated with a significant improvement in the mental dimension 
of HRQL despite moderate weight loss [181].
An interesting finding in the MOBIL-study discussed in paper II was a greater overall 
increase in the physical activity level of the ILI group compared to that of the RYGB group 
(p = .022) [140, 182]. Changes in physical activity were not connected to changes in HRQL 
in our study. Reviews and meta-analyses of the scientific literature have  shown significant 
associations in other studies between increasing levels of physical activity and improved 
HRQL in the general population [183, 184] and in morbid obesity [185], albeit that there are 
few randomised trials testing the effect of physical activity on HRQL in morbid obesity. In a 
randomised trial of sedentary, overweight and obese (BMI range 25-43 kg/m2)
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postmenopausal women with elevated systolic blood pressure, physical activity improved 
physical and mental HRQL in a dose-dependent fashion, whilst the improvements in HRQL 
were independent of weight loss [131].
5.2.3 Validation of SF 36
Our validation of this instrument questions the structural validity of the subscale scores.
However, our results do not dissuade the use of SF-36 in studies of morbid obesity, but there 
are some important considerations and limitations to the use of SF-36 as an outcome measure 
in this population. Firstly, the clinical interpretation of the subscale scores is obscured due to 
ambiguity regarding their meaning. Researchers utilizing the SF-36 subscales should be aware 
of this and use obesity-specific HRQL instruments as supplementary measures. The subscale 
scores of the SF-36 will probably be more adequately interpreted when compared to such 
diagnosis-specific instruments. Secondly, despite the high validity of the summary scales, 
there are disadvantages to using them at the expense of the subscales. The most important is 
related to the loss of information. The ‘physical summary scale’ consists of 21 items and the 
‘mental summary scale’ of 14 items. Consequently, a lot of detailed information is lost. 
Another disadvantage of using the summary scales is related to the scoring algorithm. Some
authors claim that the scoring algorithm, which is based on an orthogonal factor score, not 
accounting the high correlation between the two, produce unreliable results [58, 59]. The 
scale authors argue as a response that the scoring algorithm is for all practical purposes 
reasonable [60]. Again, other authors propose to adjust the scoring algorithm by using oblique 
factor rotations in the scoring algorithm [61]. As a consequence of this discourse, researchers 
planning to use the summary scales in the study of obesity should examine the literature on 
which algorithm to use and comment on their choice.
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6. Possible implications for practice
We have shown that employment is positively associated with HRQL in morbidly obese. As 
shown in paper I, one third of treatment seeking morbidly obese patients receive disability 
pensions. Clinicians should discuss the important association between employment and 
HRQL with their patients before suggesting disability pension.
We have also shown that after 1 year RYGB is a more effective improver of HRQL than ILI.
Our findings also indicate that a comprehensive ILI program focusing on physical activity,
meal reduction and behavioural change was able to induce improvements in most HRQL 
dimensions. Long term studies of bariatric surgery like the Swedish SOS-study [109, 110]
have shown increasing weight and decreasing HRQL amongst bariatric patients over time,
underscoring the importance of lifestyle change. Clinicians should emphasise to patients that 
bariatric surgery is primarily a means of achieving lifestyle change rather than a “final 
solution” for obesity. Given the promising results of the ILI, bariatric patients regaining 
weight should be referred to intensive lifestyle treatments.
RYGB is associated with a wide range of complications [111-114], with patients most likely
having to take dietary supplements for the rest of their lives. Given the very low complication
rate following ILI, RYGB may not, despite its ability to improve HRQL and risk factors 
[140], be the primary option. Clinicians should discuss the possible complications of RYGB
with their patients and should consider ILI as an alternative to RYGB. 
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7. Implications for further research
The prevalence of adult LQGLYLGXDOVZLWK%0,NJP2 in Norway is estimated to be 5% in 
men and 1.5% in women [11]. It is obvious that research should focus on obesity prevention
methods, especially those aiming to help children and adolescents. For society at large, public 
health research should aim to evaluate initiatives which hinder the expansion of obesogenic
structures in our culture. 
However, we also need research focusing on different treatment alternatives for those in need 
of treatment. Unlike bariatric surgery, where RYGB is considered a “gold standard” [103], no 
similar recommendation exists in terms of ILI. We need well designed controlled randomised
studies comparing the effects of different ILI’s on HRQL and other parameters like weight 
loss, physical fitness and comorbidities. We also need studies which evaluate the long-term
effect of ILI’s on HRQL.
The design of more effective lifestyle programs aiming at the improvement of patient HRQL 
is important. Several studies [124, 131, 137-139, 180, 181, 183-185] indicate that an 
expansion of the ILI’s program mode, both in terms of its content (eg. physical activity,
nutrition and behavioural focus) and length will give more positive results, both in terms of
HRQL but also in terms of weight loss. 
In sum, psychosocially oriented ILI’s which aim to increase physical activity and eating 
patterns through behavioural change are promising. However, conservative treatment 
programs for the morbidly obese are relatively new. Systematic evaluations of different 
programs are still needed in order to develop more effective ILI’s. 
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Studies of ILI should also explore the economic costs of the treatment in order to develop
more cost-effective treatments. Cost is an important factor given that the aim is to help as 
many morbidly obese individuals as possible.
8. General conclusions
We conclude that employed morbidly obese subjects have higher HRQL than their 
unemployed peers. Employment was independently associated with both the physical and 
mental dimensions of HRQL, controlling for age, gender, current BMI, obesity history, 
marital status and comorbidities. Conversely, gender (and not employment) was associated 
with the emotional dimension of HRQL. 
We can also conclude that morbidly obese patients following a part residential 
multidisciplinary lifestyle intervention program improved their HRQL, although patients 
undergoing bariatric surgery experienced larger improvements in HRQL after 1 year. The 
higher clinical relevance of bariatric surgery in terms of HRQL may be explained by a higher 
weight loss. 
Finally, we conclude that when measuring HRQL, the summary scales of the SF-36 have
satisfactory construct validity in patients with morbid obesity, although the subscale scores 
should be interpreted with care. The summary scales of the SF-36 may be considered the 
primary scales when assessing HRQL in morbidly obese patients initiating lifestyle treatment.
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Abstract
Background We aimed to investigate whether employment
status was associated with health-related quality of life
(HRQoL) in a population of morbidly obese subjects.
Methods A total of 143 treatment-seeking morbidly obese
patients completed the Medical Outcome Study 36-Item
Short-Form Health Survey (SF-36) and the Obesity and
Weight-Loss Quality of Life (OWLQOL) questionnaires.
The former (SF-36) is a generic measure of physical and
mental health status and the latter (OWLQOL) an obesity-
specific measure of emotional status. Multiple linear
regression analyses included various measures of the
HRQoL as dependent variables and employment status,
education, marital status, gender, age, body mass index
(BMI), type 2 diabetes, hypertension, obstructive sleep
apnea, and treatment choice as independent variables.
Results The patients (74% women, 56% employed) had a
mean (SD, range) age of 44 (11, 19–66) years and a mean
BMI of 44.3 (5.4) kg/m2. The employed patients reported
significantly higher HRQoL scores within all eight sub-
scales of SF-36, while the OWLQOL scores were compa-
rable between the two groups. Multiple linear regression
confirmed that employment was a strong independent
predictor of HRQoL according to the SF-36. Based on part
correlation coefficients, employment explained 16% of the
variation in the physical and 9% in the mental component
summaries of SF-36, while gender explained 22% of the
variation in the OWLQOL scores.
Conclusion Employment is associated with the physical
and mental HRQoL of morbidly obese subjects, but is not
associated with the emotional aspects of quality of life.
Keywords Employment . Obesity . Health-related quality
of life
Introduction
Health-related quality of life (HRQoL) refers to the impact of
a medical condition on the physical, social, and emotional
functioning reported by a respondent. HRQoL is often
assessed by standardized questionnaires, the generic SF-36
being the most commonly used [1]. Several lines of evidence
indicate that there is a relationship between increasing levels
of obesity and impaired HRQoL [2, 3], the latter of which
has been shown to improve after bariatric surgery [4, 5].
A number of studies have addressed the relationship
between socioeconomic factors and the impaired HRQoL
of obese persons, with at least three finding significant
associations between marital status, income, education, and
the HRQoL [6–8]. There is also some evidence to suggest
that obesity-related comorbidities and conditions such as
hypertension and type 2 diabetes may influence HRQoL in
morbidly obese women and men [3, 7, 8]. However,
previous studies have taken into account only a limited
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number of comorbidities and have done so with variable
diagnostic precision. Some of these studies are devoid of
socioeconomic considerations in their analyses.
Morbidly obese women have been found to have lower
HRQoL than men, particularly in terms of the impairment
of physical function and body image/body satisfaction [9–
11]. In addition, white subjects would seem to have lower
quality of life than other ethnic groups [10, 11]. Finally,
morbidly obese patients seeking surgery have been shown
to have lower HRQoL than those who do not [12].
A study of 51 morbidly obese subjects treated with
duodenal switch [6] demonstrated a statistically significant
association between employment and the physical and
mental component scores of the SF-36. The study was,
however, limited by lack of adjustments for obesity-related
comorbidities and conditions which might have influenced
HRQoL. In addition, no obesity-specific measure of quality
of life was addressed.
We aimed to investigate whether the general and obesity-
specific HRQoL of treatment-seeking morbidly obese
Caucasian subjects were associated with employment status
after adjustments for confounding factors.
Materials and Methods
Study Design and Participants
The non-randomized controlled MOBIL study (Morbid
Obesity treatment, Bariatric surgery versus Intense Lifestyle
intervention, Clinical Trials.gov number NCT00273104)
was designed to compare the effects of bariatric surgery and
intensive lifestyle intervention on various comorbidities,
eating behavior, and quality of life [13]. In the present
cross-sectional study, 145 patients were asked to complete
two questionnaires related to HRQoL at baseline. Two
patients did not complete the questionnaires, and as such,
data from 143 morbidly obese subjects, all but one
Caucasian, was included in the analysis.
The regional Ethics Committee for Medical Research
approved the study protocol, and the study was performed
in accordance with the Declaration of Helsinki. All
participants gave informed written consent before enrol-
ment. We certify that all applicable institutional and
governmental regulations concerning the ethical use of
human volunteers were followed during this research.
Outcomes, Explanatory Variables, and Potential
Confounders
The main outcome was HRQoL as measured by various
questionnaires exploring the physical, mental, and emo-
tional aspects. The main explanatory variable was employ-
ment status, with possible confounders adjusted for
including socioeconomic factors, age, gender, body mass
index (BMI), obesity-related comorbidities, and treatment-
seeking status. Persons receiving income from either full-
time or part-time work were defined as employed.
HRQoL
Two different questionnaires were used to measure
HRQoL: the Medical Outcome Study 36-Item Short-Form
Health Survey (SF-36) and the Obesity and Weight-Loss
Quality of Life (OWLQOL). SF-36 is a commonly used
generic measure of health status based on a comprehensive
set of items. It has eight subscales (physical function, role
physical, bodily pain, general health, role emotional, social
function, vitality, and mental health), which generate two
general health summaries: the physical and mental compo-
nent scores [14, 15]. The OWLQOL primarily measures the
emotions and feelings which result from being obese and
trying to lose weight. The instrument consists of 17
statements about weight and quality of life. All items are
rated on a seven-point scale from 0 (not at all) to 6 (a lot),
with lower scores better than higher. The OWLQOL scale
is adjusted to 0–100 (higher = better) after reversing the
scores. The OWLQOL was originally produced at the
University of Washington and has been further developed
through input from five European countries and the USA.
The questions have been translated into Norwegian and are
available with permission from the Seattle Quality of Life
Group, University of Washington [16, 17].
Clinical Examination
All participants underwent a medical examination by a
physician during their first consultation. Demographic data,
socioeconomic history, and medical history were recorded
using standardized schemes. Weight and height were
measured with patients wearing light clothing and no shoes.
BMI was calculated as weight in kilograms divided by the
square of the height in meters. Blood pressure was
measured three times after at least 5 min rest, at the right
or left brachial artery, with the patient in a sitting position.
The average of the second and third measurements was
registered. Hypertension was confirmed if either systolic
blood pressure was greater than 140 mmHg, if diastolic
blood pressure was greater than 90 mmHg, or if the patient
received antihypertensive drugs.
All patients underwent one overnight sleep with a
portable monitor, the Embletta™ system; which has both
high sensitivity and specificity when compared to the “gold
standard” overnight polysomnography used to identify
obstructive sleep apnea (OSA) patients [18]. OSA was
diagnosed in patients having moderate to severe sleep
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apnea (apnea–hypopnea index (AHI)≥15 events per hour)
as these patients are more likely to have symptoms than
those with mild OSA.
Type 2 diabetes was diagnosed in patients either treated
with glucose-lowering drugs or with a fasting serum glucose
≥7.0 mmol/l and/or a 2-h glucose ≥11.1 mmol/l after the
ingestion of a 75-g anhydrous glucose solution [13].
In addition, all patients completed a questionnaire on
their diet and physical activity [19]. Patients were catego-
rized as having a sedentary lifestyle if they had no (less
than 10 min a week) aerobic moderate or vigorous activity
based on their answer to the following question: “Do you
perform any physical activity and exercise making you a
little short of breath (more than 10 min a week bicycling,
swimming, walking, skiing, dancing, or golfing)?”
Statistical Analysis
Data are presented as mean (SD) or n (percent) unless
otherwise stated. The reliability of the HRQoL scales was
assessed with inter-item analysis using Chronbach's alpha.
The scales were examined for normality using skewness
tests and Kolmogorov–Smirnov testing. None of the scales
had significant departures from normality. The continuous
independent variables underwent the same normality testing
and neither was found to have significant departures from
normality.
Between group comparisons were analyzed using inde-
pendent samples t test and χ2. The correlation between each
of the independent and the dependent variables was
calculated using Pearson correlation coefficient. We also
performed three multiple linear regression analyses, one for
each scale as the dependent variable. Ten predefined
explanatory variables were included in each model. In
examining the variation of inflation factors in the models,
we found no consequential multicollinearity between the
independent variables. The probability–probability plot
between expected and observed cumulative distribution was
considered acceptable. Semi-partial (part) correlation coeffi-
cients were squared in order to calculate the percentage of
total variance in the dependent variable explained by a given
independent variable. Throughout, we report two-tailed P
values, as we considered values below .05 to be statistically
significant. Particular attention should, however, be directed
towards small P values, e.g., those below .01, because a
considerable number of P values have been calculated. The
statistical analysis was conducted using SPSS v.17.0.
Results
The reliability of the scales as measured by the
Chronbach's alpha was 0.93 for the SF-36 and 0.95 for
the OWLQOL. Table 1 shows demographic, socioeco-
nomic, and clinical characteristics according to employ-
ment status. The 143 morbidly obese patients (74%
women) had a mean (SD, range) age of 44 (11, 19–66)
years and a mean BMI of 44.3 (5.4) kg/m2. The
employment rate was 56%. The employed and unem-
ployed groups were comparable with respect to age,
gender, BMI, sedentary lifestyle, and obesity-related
comorbidities (Table 1).
Nearly all of the unemployed patients (91%) received
benefits from the state, including disability benefits (38%),
rehabilitation benefits (24%), sick leave (16%), unem-
ployment benefits (5%), retirement pensions (5%), and
unknown (3%). The unemployed group had a significantly
lower average level of education and tended to opt for
bariatric surgery more often than their employed counter-
parts (Table 1).
The physical and mental scores of SF-36 were signifi-
cantly higher in the employed group than the unemployed
group (Table 1). The emotional aspects of quality of life as
measured with the OWLQOL did not differ between the
two groups (P=.86).
Differences between the employed and the unemployed
groups within the various subscales of SF-36 are shown in
Fig. 1. The employed patients reported significantly higher
HRQoL within all eight subscales; this was most pro-
nounced within the physical function, role physical, bodily
pain, and role emotional subscales.
The multiple linear regression models (Table 2) con-
firmed that employment was significantly associated with
higher scores for general physical and mental health
according to both SF-36 dimensions after adjustment for
confounding factors. In contrast, only gender was
significantly associated with the emotional aspects of
obesity as measured by the OWLQOL (women had
lower scores than men). Neither age, level of obesity,
comorbidities, nor education were significantly associated
with HRQoL.
Squared part correlations showed that employment
explained 16% of the variation in the physical component
score of the SF-36 and 9% of the variation in the mental
component score of the SF-36. Gender explained 22% of
the variation in the OWLQOL scores.
Discussion
Our study demonstrates that in morbidly obese patients
allocated to either surgical treatment or lifestyle interven-
tion, employment was independently associated with both
the physical and mental aspects of HRQoL. Conversely,
employment was not associated with the emotional aspects
of quality of life.
1706 OBES SURG (2011) 21:1704–1709
Employment
Our study confirms the findings of previous studies which
demonstrated a relationship between participation in paid
work and general HRQoL in patients undergoing bariatric
surgery [6, 20]. Through our study, we are able to both
extend this association to a sample of morbidly obese
subjects offered either conservative or surgical treatment
and to suggest that it is valid independent of confounding
factors. However, we found no association between the
emotional aspects of quality of life and employment status.
Our findings are also in accordance with a previous
study of patients with inflammatory bowel disease, which
showed that employment was associated with HRQoL as
measured by SF-36 [21]. It could be argued that employed
patients use their physical and mental capacities and might
therefore pay less attention to any general health limitations
and discomfort they may have. Employment might give
both a sense of inclusion and belonging, providing patients
with access to both working and social networks. This
hypothesis is supported by studies of both cancer patients
and older adults which have shown positive associations
between social networks, support, and HRQoL [22, 23].
Employment may also positively contribute to a person's
self-esteem. Nevertheless, in the present study, emotional
QoL was comparable among both employed and unem-
ployed patients, indicating that participation in paid work
does not seem to relieve the emotional distress of being
morbidly obese [24].
Fig. 1 The SF-36 subscale mean scores among employed and
unemployed patients. The SF-36 subscales differed significantly
between employed (light grey) and unemployed (dark grey) patients.
Independent samples t test; *** p<0.001, **p<0.01, *p<0.05
Variable Total Employed (n=80) Unemployed (n=63) P value
Age (years) 44.6 (10.7) 44.1 (10.2) 45.2 (11.3) 0.557
Women 106 (74%) 63 (79%) 43 (68%) 0.180
Start obesity
<12 years 34 (25%) 22 (28%) 12 (20%)
12–20 years 32 (23%) 14 (18%) 18 (30%)
>20 years 72 (52%) 42 (54%) 30 (50%) 0.207
BMI (kg/m2) 44.3 (5.4) 43.7 (5.6) 45.0 (5.2) 0.180
Current smoker (yes) 38 (27%) 19 (24%) 19 (31%) 0.445
Sedentary lifestyle (yes) 36 (31%) 21 (33%) 15 (28%) 0.689
Socioeconomic factors
Married/cohabitant (yes) 89 (62%) 54 (68%) 35 (56%) 0.166
Length of education
Basic (<9 years) 35 (25%) 9 (11%) 26 (42%)
Intermediate (9–12 years) 72 (51%) 49 (61%) 23 (38%)
Higher (>12 years) 34 (24%) 22 (28%) 12 (20%) <0.001
Comorbidities
Hypertension (yes) 52 (36%) 28 (35%) 24 (38%) 0.729
Type 2 diabetes (yes) 44 (31%) 24 (30%) 20 (32%) 0.855
OSA (AHI ≥15; yes) 43 (31%) 21 (27%) 22 (37%) 0.267
Seeking surgery (yes) 84 (59%) 41 (51%) 43 (68%) 0.059
Quality of life
SF-36 physical 46 (24) 55 (22) 33 (20) <0.001
SF-36 mental 55 (25) 62 (23) 47 (24) 0.001
OWLQOL emotional 35 (24) 35 (23) 35 (25) 0.864
Table 1 Demographic, socio-
economic, and clinical charac-
teristics among 143 morbidly
obese subjects according to
employment
Data are given as mean (SD) or
number (percent). P values were
calculated using independent
samples t test or χ2
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The employment rate among the patients was 56%,
while the overall Norwegian employment rate at the same
time of the study was 73% [25]. A large proportion of the
jobs patients held were within low wage service sectors like
transport, accommodation, and food and health (data not
shown). The Norwegian welfare system provides a signif-
icant range of benefits for persons without work. We
therefore believe that poverty plays a minor role in
explaining why unemployed morbidly obese patients
reported impaired HRQoL.
Gender
The general physical and mental HRQoL scores were
nearly equal between the morbidly obese men and women
in the study. However, the obesity-specific emotional
measurement OWLQOL showed that women reported
significantly more concerns about emotional and social
distress. Previous studies have demonstrated impaired
HRQoL among morbidly obese women [9, 10]. Some
authors have also suggested there to be less social obesity
stigmatization among African American women [11]. Our
study confirms that for white females, obesity has a
stronger effect upon the emotional quality of life than the
general HRQoL. The question whether this finding is also
valid for women of other ethnicities should be addressed in
future studies.
Comorbidities
We found no statistically significant associations between
weight-related comorbidities and quality of life. This
finding concurs with at least one previous study [3]. Most
patients had either no symptoms or only mild symptoms as
a result of the comorbidities and did not seem to be very
bothered by these. Many of them were not even aware of
their comorbidity before the study examination. Thus, it
seemed that being unemployed overshadowed the potential
problems following hypertension, obstructive sleep apnea,
and type 2 diabetes.
Treatment-Seeking Status
In accordance with previous studies [11, 12, 26], patients
seeking surgery reported significantly lower physical health
according to the SF-36. However, patients in many of these
studies did not have any appropriate alternative to surgery.
In the MOBIL study, by contrast, patients had two different
obesity treatment choices: bariatric surgery or an intensive
(partly residential) lifestyle program.
Limitations
Our cross-sectional study has limitations. Firstly, the
finding of a positive association between work status and
HRQoL does not infer any causal relationship. As such,
there is a need for further exploration through longitudinal
studies. Secondly, the “healthy worker effect,” a phenom-
enon of any group of workers likely to be more healthy
than the population as a whole, can give rise to both
selection and confounding bias [27]. Occupational groups
of patients often have fewer illnesses and disabilities and as
such are more likely to be healthy than the patient
population as a whole. Thirdly, it may be hypothesized
that various levels of disability partly explain both poor
HRQoL and unemployment. Unfortunately, since the
precise level of disability was not assessed in the present
study, we could not test this hypothesis. Finally, our results
may not be valid in non-white populations.
Conclusions
In summary, our study of predominantly white morbidly
obese subjects has shown that being employed was
significantly associated with better general physical and
QOL dimension Physical, R2=0.36, beta Mental, R2=0.17, beta Emotional, R2=0.26, beta
Gender 0.13 0.15 0.51***
Age −0.22* 0.07 0.07
BMI −0.09 0.13 −0.15
Marital status −0.09 −0.02 0.05
Education −0.07 −0.06 0.01
Employment 0.43*** 0.33** 0.07
Hypertension 0.03 0.01 0.16
OSA −0.09 −0.03 0.06
Type 2 diabetes −0.14 −0.11 −0.04
Seeking surgery 0.26** 0.12 0.13
Table 2 Predictors of HRQoL
in 144 morbidly obese patients
The main explanatory variable
was employment status, with
possible confounders adjusted
for including other socioeco-
nomic factors, age, gender,
BMI, obesity-related comorbid-
ities, and treatment-seeking sta-
tus. Standardized beta values are
given
*P<0.05; **P<0.01; ***P<
0.001 (linear regression)
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mental HRQoL and that female gender was significantly
associated with the negative emotional results of obesity.
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Abstract
Background: There is little robust evidence relating to changes in health related quality of life (HRQL) in morbidly
obese patients following a multidisciplinary non-surgical weight loss program or laparoscopic Roux-en-Y Gastric
Bypass (RYGB). The aim of the present study was to describe and compare changes in five dimensions of HRQL in
morbidly obese subjects. In addition, we wanted to assess the clinical relevance of the changes in HRQL between
and within these two groups after one year. We hypothesized that RYGB would be associated with larger
improvements in HRQL than a part residential intensive lifestyle-intervention program (ILI) with morbidly obese
subjects.
Methods: A total of 139 morbidly obese patients chose treatment with RYGB (n=76) or ILI (n=63). The ILI
comprised four stays (seven weeks) at a specialized rehabilitation center over one year. The daily schedule was
divided between physical activity, psychosocially-oriented interventions, and motivational approaches. No special
diet or weight-loss drugs were prescribed. The participants completed three HRQL-questionnaires before treatment
and 1 year thereafter. Both linear regression and ANCOVA were used to analyze differences between weight loss
and treatment for five dimensions of HRQL (physical, mental, emotional, symptoms and symptom distress)
controlling for baseline HRQL, age, age of onset of obesity, BMI, and physical activity. Clinical relevance was
assessed by effect size (ES) where ES<.49 was considered small, between .50-.79 as moderate, and ES>.80 as large.
Results: The adjusted between group mean difference (95% CI) was 8.6 (4.6,12.6) points (ES=.83) for the physical
dimension, 5.4 (1.5–9.3) points (ES=.50) for the mental dimension, 25.2 (15.0–35.4) points (ES=1.06) for the emotional
dimension, 8.7 (1.8–15.4) points (ES=.37) for the measured symptom distress, and 2.5 for (.6,4.5) fewer symptoms
(ES=.56), all in favor of RYGB. Within-group changes in HRQOL in the RYGB group were large for all dimensions of
HRQL. Within the ILI group, changes in the emotional dimension, symptom reduction and symptom distress were
moderate. Linear regression analyses of weight loss on HRQL change showed a standardized beta-coefficient of
–.430 (p<.001) on the physical dimension, –.288 (p=.004) on the mental dimension, –.432 (p<.001) on the emotional
dimension, .287 (p=.008) on number of symptoms, and .274 (p=.009) on reduction of symptom pressure.
Conclusions: Morbidly obese participants undergoing RYGB and ILI had improved HRQL after 1 year. The weaker
response of ILI on HRQL, compared to RYGB, may be explained by the difference in weight loss following the two
treatments.
Trial registration: Clinical Trials.gov number NCT00273104
Keywords: Quality of life, Bariatric surgery, Lifestyle modification
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Introduction
Morbid obesity is understood as a body mass index
(BMI) ≥40 kg/m2 or BMI ≥35 kg/m2 with comorbidities
[1]. Roux-en-Y Gastric Bypass (RYGB) is an effective
and commonly used [2] surgical procedure for treatment
of morbid obesity. Although the majority of patients
may prefer non-surgical intervention, bariatric surgery
has been shown to be more effective than lifestyle inter-
vention at improving weight loss and obesity associated
morbidities [3,4].
Improving patients’ health-related quality of life (HRQL)
is an important treatment goal. This concept refers to
how well an individual functions in daily life and their
perceived well-being [5]. In accordance with the World
Health Organization’s multidimensional definition of
health [6], we conceptualize HRQL as encompassing
physical, mental and emotional dimensions as well as the
burden of obesity specific symptoms.
Few studies have addressed the comparative effects of
bariatric surgery and lifestyle intervention on HRQL. The
Swedish Obese Subjects research program (SOS), a 10-year
non-randomized controlled longitudinal study, compared
patients undergoing various bariatric procedures (n=655)
with patients (n=621) undergoing conventional weight-loss
treatment [7]. Notably, treatment for the conventionally
treated patients was not standardized and treatment
regimens varied according to local practices. The Swedish
study showed that patients who chose surgery lost about
15 times more weight than non-surgically treated patients,
mean (SD) loss of 19.7 (15.8) kg vs. 1.3 (13.8) kg. In
addition, the study reported that the surgical groups
sustained positive outcomes in HRQL compared to non-
surgical matched controls. This effect was mainly explained
by weight loss. A two-year controlled non-randomized
study by Kolotkin et al. [8] found significant improvements
in HRQL in patients undergoing RYGB (n=308) compared
to a control group of patients who sought but did not
undergo RYGB (n=253) and a population-based group of
obese individuals (n=272).
Notably, neither study predefined the lifestyle interven-
tion for the non-surgical groups making comparison
between bariatric surgery and comprehensive lifestyle
programs difficult. The evidence thus remains limited
regarding HRQL following RYGB in comparison to specific
comprehensive and multidisciplinary lifestyle interventions.
In addition, most studies of HRQL in morbid obesity have
focused on the physical and mental aspects, applying gen-
eric instruments of HRQL measurement. However, the de-
velopment of obesity-specific HRQL instruments enables
additional analyses of the emotional and symptomatic
dimensions. Furthermore, only a few studies of HRQL in
the morbidly obese have calculated the effect size (ES) of
change in HRQL, which underscores the clinical relevance
of the various treatments.
An earlier report [9] demonstrated that type 2 diabetes
and obesity-related cardiovascular risk factors such as
hypertension and hyperlipidemia were improved after
both RYGB and a pre-defined part residential multidis-
ciplinary non-surgical intensive lifestyle-intervention
program (ILI). However, the improvements were greatest
in those patients treated with RYGB. This study did not
evaluate the individuals’ subjective notion of well-being
or how their daily life functioned following these two
interventions.
The aim of the present study was to describe and
compare changes in five dimensions of HRQL (physical,
mental, emotional, number of symptoms, and symptom
distress) following RYGB and ILI in morbidly obese
subjects. Secondarily, we wanted to assess the clinical
relevance of the changes in HRQL between and within
these two groups after one year. We hypothesized that
RYGB would be associated with larger improvements of
HRQL than ILI in morbidly obese subjects.
Methods and procedures
This is a preplanned analysis of data from the MOBIL-
study (Morbid Obesity treatment, Bariatric surgery ver-
sus Intensive Lifestyle intervention, Clinical Trials.gov
number NCT00273104), a non-randomized controlled
study designed to compare the effects of bariatric sur-
gery and intensive lifestyle intervention on various
comorbidities, eating behavior and HRQL.
A total of 228 patients were screened, with 47 found
not to be eligible. Of the remaining 181 participants 35
were not enrolled, leaving 146 in the study (Figure 1,
flow of participants).
During the screening procedure all eligible patients
underwent a thorough assessment at the Morbid Obesity
Center by a multidisciplinary team consisting of an in-
ternist, a dietician, a physiotherapist and a trained “obes-
ity” nurse. Patients were provided information about
the possible risks and benefits of an operation and
also encouraged to incorporate their own values and
preferences into the decision-making process. If no
contraindication against surgery existed, the patient and
the physician together agreed upon the most appropriate
choice of therapy; either surgical or conservative [10].
A previous report [9] showed a mean (SD) 1-year weight
loss of 30 (8)% of initial body weight in the RYGB group
and 8 (9)% in the ILI group. This corresponds to a mean
(SD) loss of excess weight above 25 kg/m2 of 67% (18) and
20% (23) (P<0.001) respectively. The patients in the RYGB
group lost a mean (SD) of 14.0 (4.1) BMI points and the ILI
group 3.7 (4.2) BMI points. The number of subjects in the
RYGB group and ILI group who either moved from being
inactive to active (12 vs 18), stayed inactive or active (57 vs
32), or moved from being active to inactive (4 vs 5), differed
significantly between the groups. Overall, there was a greater
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increase in the physical activity level of the lifestyle group
compared to the surgery group.
The Norwegian Regional Ethics Committee for Med-
ical Research approved the study protocol (S-05175),
and the study was performed in accordance with the
Declaration of Helsinki. All participants gave informed
written consent before enrolment.
Variables, measurement and outcomes
The main outcome in the current analysis was the
change in each of the five dimensions of HRQL,
conceptualized as encompassing physical, mental and
emotional dimensions, as well as the number and bur-
den of obesity-specific symptoms. Since we aimed to
compare the effect of two treatment methods, and since
entering both weight loss and type of treatment into the
same statistical analysis led to multicollinearity (r=.81),
weight loss was excluded from the multiple regression
analyses of covariance (ANCOVA). Variables that were
considered possible confounders included age and BMI
prior to intervention, age at the onset of obesity, physical
activity and HRQL-score prior to intervention. Three
questionnaires were used to measure HRQL: the Med-
ical Outcome Study 36 – Item Short Form Health
Figure 1 Flow of patients.
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Survey (SF-36), the Obesity and Weight-Loss Quality of
Life (OWLQOL), and the Weight Related Symptom
Measure (WRSM).
Medical Outcome Study 36 – Item Short Form Health
Survey (SF-36)
SF-36 is a commonly used generic measure of HRQL
based on 36 questions or items [11-13]. Item 2 is not
included in the scoring of the instrument [13]. The
remaining 35 items form eight subscales (physical
function, role physical, bodily pain, general health, role
emotional, social function, vitality, and mental health)
which can be combined into two summary scores; the
physical and mental dimensions [14]. As the validity of
the subscales in morbidly obese patients is uncertain
[15,16] we studied the physical and mental dimensions.
The calculations were performed as recommended by
the scale authors [14], using Norwegian norms [17]
and oblique factor scores to account for the correl-
ation between the two HRQL-dimensions. The scores
were calculated by multiplying each subject’s SF-36
subscale z score by its respective factor coefficient and
then standardizing each to a T score with a mean of
50 and a standard deviation of 10 [14]. Both scales
were set to a range from 0–100, where higher scores
indicate better HRQL.
Obesity and Weight-Loss Quality of Life (OWLQOL)
The OWLQOL [18,19] primarily measures emotions
and feelings [20,21] which are believed to result from
being obese and trying to lose weight. The instrument
consists of 17 statements about weight-related feelings
and emotions which are rated on a seven-point scale
that ranges from 0 (“not at all”) to 6 (“a very great deal”).
The 17 items of the OWLQOL form a scale ranging
from 0–102, with higher scores indicating greater emo-
tional HRQL.
Weight Related Symptom Measure (WRSM)
The WRSM [18,19] measures 20 obesity-specific symp-
toms using two different sets of items. The first set
assesses whether or not the patient is experiencing spe-
cific symptoms. The scoring of this set of items creates
an additive scale summing up the number of symptoms,
ranging from 0–20. The second set of items concerns
the distress of the symptoms, with values from 0 (“not at
all”) to 6 (“bothers a very great deal”). They form a
symptom distress scale ranging from 0–120, where
higher scores indicate greater symptom distress. Both
the OWLQOL and the WRSM were obtained with per-
mission from the Seattle Quality of Life Group, Univer-
sity of Washington.
In sum, the three HRQL questionnaires constitute five
different measurements of HRQL; physical dimension
(SF-36), mental dimension (SF-36), emotional dimension
(OWLQOL), number of obesity symptoms (WRSM),
and distress of obesity symptoms (WRSM).
Changes in scores between two time-points or groups
can be statistically significant. An important follow-up
question is whether the changes are clinically relevant.
There are different approaches to addressing this. Here
we have chosen the effect size (ES) to grade the effi-
ciency of surgical versus nonsurgical treatment [22,23].
Physical activity was assessed through structured
interviews performed by registered dieticians. Time
spent performing light (e.g. casual walking), moderate (e.
g. brisk walking) and vigorous (e.g. jogging) intensity
aerobic physical activities for periods of 10 minutes or
more was recorded. Participants who performed 150
minutes or more per week of moderately intense aerobic
physical activities were considered to be physically ac-
tive, as were those participants who performed 60
minutes or more per week of vigorously intense aerobic
physical activities [24].
Participants
A total of 139 patients completed the MOBIL-study
(Figure 1). At baseline, all patients in both the RYGB
group (n=76) and the ILI group (n=63) completed the
three HRQL instruments. At 1 year follow up 62 (82%)
participants in the RYGB group and 48 (76%) in the ILI
group had completed the questionnaires. In order to as-
sess the representativeness of the sample at the end of
the study we used an independent samples t-test to
compare differences between patients not completing
the questionnaires at the end of the study versus
completers. Patients who did not complete the
questionnaires after 1 year (n=29) were comparable with
those who did (n=110) with regards to baseline HRQL,
gender, age, body weight, employment status, and weight
loss after 1 year (data not shown).
Interventions
During follow-up, patients allocated to RYGB were
examined by a bariatric surgeon 6 weeks after surgery,
while patients were seen by a dietician quarterly, usually
in groups of 12–16. The patients in the ILI group were
admitted to a rehabilitation center specializing in the
care of morbidly obese patients. The aim was to attain a
sustained 1-year weight loss ≥10%. Each patient was
encouraged to increase their physical activity and to
normalize eating habits. The program intended to in-
crease each patient’s self-efficacy in dealing with their
weight problem, as well as an improvement in self-
esteem.
The 1-year lifestyle program comprised four stays at the
rehabilitation center – three 5-day stays in weeks 1, 26,
and 51, and a four-week stay from weeks 13–17 (Figure 2).
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The daily schedule was divided between organized daily
physical activity (3–4 hours) and various psychosocially-
oriented interventions combined with a motivational
approach both in group sessions and individual sessions
(3–4 hours). These sessions were supervised by a medical
doctor, nutritionists, physiotherapists and mental health-
trained nurses. No special diet or weight-loss drugs were
prescribed, but patients were encouraged to follow the
guidelines of the Norwegian National Council of Nutrition
[25], which recommends that the daily intake of protein,
fat, carbohydrate and alcohol should account respectively
for 10–20, <30, 50–60, and <5% of energy consumed. In
addition, the patients were asked to reduce their daily total
energy intake, but not using calorie-counting. Outside of
these stays patients were contacted by phone once every 2
weeks. They were also encouraged to self-monitor their
eating habits and physical activities in a pre-fabricated
diary, as well as to consult their general practitioner for
weight measurement and follow-up every four weeks.
Statistical methods
Data are presented as mean (SD) or n (%) unless other-
wise stated. Skewed data were transformed to approxi-
mate normality using natural logarithms. To assess the
reliability of the HRQL-scales we calculated Cronbach’s
alpha coefficients.
After applying Little’s test of randomness of missing
data, missing values (SF-36:23.5%, OWLQOL:24.5%,
WRSM:23.7%) were imputed using multiple imputation.
The imputation model consisted of the HRQL-scores,
physical activity at baseline and 1 year, and age of onset
of obesity as predictor and imputation variables, and
treatment, gender, age, baseline BMI, marital status, em-
ployment, and education as predictor variables. Through
a fully conditional specification model, applying linear
regression as the prediction method for scale variables
and two-way interactions for categorical variables, we
generated twenty complete datasets for each of the
HRQL-scores with 10 iterations per dataset. The statis-
tical analyses were performed on each complete dataset,
and thereafter the multiple analyses results were
combined to achieve single estimates. The combined
estimates are presented. Observing the fraction of
missing information, relative increase variance, and rela-
tive efficiency, the imputed data-sets (n=139) were com-
parable with the original data-set (n=110) in terms of
the imputed variables (data not shown).
Within-group analyses in both groups were performed
using paired samples t-test. Between-group comparisons
at baseline were analyzed using independent samples t-
test for continuous variables and χ2 for categorical
variables.
Within groups ES was calculated as the mean HRQL
change score between 1 year and baseline divided by the
standard deviation of the baseline HRQL. Between
groups ES was calculated as the difference in mean
HRQL change score between groups at 1 year divided by
the standard deviation of baseline HRQL [22,23]. An ES
from .20–.49 was considered small, .50–.79 as moderate,
and greater than .80 as large [22,23].
In order to avoid problems of regression towards the
mean [26,27], we applied one-way between-group ana-
lyses of covariance (ANCOVA) to compare the effect of
RYGB and lifestyle intervention on five dimensions of
HRQL. Age at baseline, age at the onset of obesity, BMI
at baseline, physical activity at baseline, and baseline
HRQL-scores were used as covariates in each of the five
analyses [28]. Assessments of normality, linearity, homo-
geneity of variance and regression slopes were
conducted to ensure assumptions for the ANCOVA.
The unadjusted changes from baseline in the RYGB
group and ILI group, together with the adjusted between
group differences (95% CI), are reported. To account for
the percentage explained variance in the dependents,
calculations of partial eta squared (ηp2) were performed.
To test the effect of weight reduction (instead of treat-
ment choice) on HRQL, multiple linear regression ana-
lyses were conducted with each of the 12 months HRQL
changes (physical, mental, emotional, number of obesity
symptoms, and symptom distress) as dependents, with
gender, age at baseline, age at the onset of obesity, BMI
at baseline, physical activity at baseline, and weight
change in per cent of baseline weight as independents.
Throughout, we report two-tailed P values, with P<.05
was considered to be statistically significant. The statis-
tical analysis was conducted using SPSS v.18.0.
Results
Internal consistency
The inter-item analyses showed Cronbach’s alpha coef-
ficients >.80, indicating that intercorrelations among the
items is high and that there is a high reliability for all
of the HRQL-scales (physical, mental, and emotional
dimensions, number of symptoms, and symptom
distress).
Figure 2 Schedule of stays during the 1-year intensive lifestyle intervention program at the rehabilitation centre.
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Patients
Baseline demographic characteristics are summarized in
Table 1. Compared to the ILI group, the patients in the
RYGB group had a higher BMI (ES=.49), were younger
(ES=.36), had earlier onset of obesity (ES=.47), and had
lower physical (ES=.50) and emotional HRQL (ES=.42).
Changes in the five main dimensions of HRQOL
Adjusted between group analyses, controlling for the
effects of treatment, age at baseline, age at the onset of
obesity, BMI at baseline, physical activity at baseline,
and baseline HRQL-scores, showed that compared to
the ILI group, the RYGB group had statistically signifi-
cant higher adjusted mean improvement in all HRQL-
measurements, especially the emotional dimension
(Table 2). Based on calculations of ηp2, type of treatment
predicted 19.7% of the variance (ES=.83) in the physical
dimension change score, 9.8% (ES=.50) in the mental di-
mension change score, 22.6% (ES=1.06) in the emotional
dimension change score, 7.7% (ES=.56) in the number of
symptoms, and 8.1% (ES=.37) in the symptom distress
change score.
Unadjusted within-group analyses showed that both
groups reported improvements in all five HRQL-
measurements (Figures 3 and 4). All effect sizes were
large within the RYGB group and small to moderate
within the ILI group.
Changes in self-reported symptom distress
Twenty common obesity specific health problems
associated with obesity are listed in Table 3. Compared
to the ILI group, the RYGB group showed greater im-
provement in ailments such as reduced physical stamina,
joint pain, snoring, sleep problems, skin irritation, water
retention, and foot problems. Only the improvements of
physical stamina and joint pain showed large effect sizes
between groups. On the other hand, the RYGB group
reported higher sensitivity to cold (Table 3), and this dif-
ference was considered large.
The effect of weight reduction
The linear regression analyses revealed significant
associations between weight reduction in per cent of
baseline weight, when controlling for the effect of gen-
der, age at baseline, age at the onset of obesity, BMI at
baseline, and physical activity at baseline. The analyses
of weight loss on HRQL change showed a standardized
beta-coefficient of –.430 (p<.001) on the physical dimen-
sion, –.288 (p=.004) on the mental dimension, –.432
(p<.001) on the emotional dimension, .287 (p=.008) on
number of symptoms, and .274 (p=.009) on reduction of
symptom pressure.
Discussion
Key results
In this non-randomized clinical trial comparing RYGB
to ILI, we found that RYGB was more effective at im-
proving all HRQL-dimension scores (Table 2). In par-
ticular, the RYGB group had a clinically relevant effect
on changes in the emotional dimension (ES=1.06) and in
the physical dimension (ES=.83). Within the RYGB
group all HRQL dimensions showed large improvements
(ES>.80). Within the ILI group, changes were moderate
(ES>.50 and <.79).
Previous studies have shown that patients treated with
RYGB experience larger improvements of HRQL
compared to those undergoing conventional weight loss
treatment [7,8]. However, these studies did not compare
the surgical procedures with a part residential lifestyle
intervention program. In addition, the authors did not
assess the effect sizes of the treatments on the various
dimensions of HRQL.
The improvement of the emotional dimension of
HRQL was particularly pronounced in the RYGB group.
Table 1 Demographic, socioeconomic and clinical
characteristics of 139 morbidly obese individuals who
chose a part residential intensive lifestyle intervention
program (ILI) or gastric bypass surgery (RYGB)
Variable Total RYGB ILI P-
value(n=139) (n=76) (n=63)
Women (n, %) 97 (70%) 53 (70%) 44 (70%) .569
Age (years), mean (SD) 46 (11) 43 (11) 47 (11) .021
Onset of obesity (n, %)
<12 years 35 (25%) 25 (33%) 10 (16%)
12-20 years 28 (20%) 17 (22%) 11 (17%)
>20 years 76 (55%) 34 (45%) 42 (67%) .003
BMI (kg/m2), mean (SD) 44 (6) 46 (6) 43 (5) <.001
Married/cohabitant, (n, %) 83 (60%) 45 (60%) 38 (60%) .895
Employment (n, %) 82 (59%) 40 (53%) 42 (67%) .094
Length of education (n, %)
Basic (<9 year) 32 (23%) 18 (24%) 14 (22%)
Intermediate (9–12 year) 75 (54%) 44 (58%) 31 (49%)
Higher (>12 year) 2 (23%) 14 (18%) 18 (29%) .358
Physical activity (n, %)
Low 115 (83%) 67 (88%) 48 (76%)
High 24 (17%) 9 (12%) 15 (24%) .063
Quality of life scores, mean (SD)
Physical dimension a 36 (10) 34 (10) 39 (10) .018
Mental dimension a 41 (11) 41 (11) 42 (11) .690
Emotional dimension b 36 (24) 32 (23) 42 (24) .047
Number of symptoms c 11 (4) 12 (4) 11 (4) .343
Symptom distress d 41 (21) 43 (21) 38 (20) .173
(a) SF-36 (scale 0–100). (b) OWLQOL (scale 0–102). (c) WRSM (scale 0–20). (d)
WRSM (scale 0–120).
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A possible explanation may be that the massive weight
loss following RYGB after 1 year reduced the patients
feeling of being fat and, accordingly, improved their
feeling of being “normal”. The surgical procedure per se
seems to help many patients gain control over their food
intake, thus confirming the clinical observation of more
“relaxed” patients one year after surgery. In addition, as
suggested by Fabricatore and Wadden [29], the negative
stigma associated with obesity may be caused by an un-
desirable body appearance and by the “character defects”
other people associate with this appearance. In our
terms, as patients start to experience massive weight
loss, their perception of their own body is expected to
improve, as is the perceptions of other people. This in-
ternal and external reduction of stigma may be followed
by an improvement in self-esteem and positive emotions
among obese patients experiencing massive weight loss.
However, a massive weight loss and a less stigmatizable
body appearance may not be the only explanations as to
the improvements in the emotional HRQL. The ILI
group also reported significant improvements in the
emotional dimension of HRQL after 1 year, even though
the effect size was moderate. The moderate effect in the
ILI group may be explained by the more moderate
weight loss in this group. However, weight loss may not
be the only explanation. It is conceivable that the inter-
vention itself added to the improvement of emotional
HRQL in the ILI group. The group-based focus and mo-
tivational approach in the lifestyle program aimed at
increasing self-efficacy, self-esteem and mood state. Pre-
vious studies seem to support this notion. Programs fo-
cusing on motivationally-oriented group sessions report
as little as 3 kg. weight loss (e.g. from 103 to 100 kg.)
but have found significant improvements in mood state
as measured with validated psychometric instruments
[30]. In another study of 440 obese patients with
Table 2 One way between-groups analysis of variance on five dimensions of HRQL in morbidly obese patients
undergoing either RYGB or ILI
Changes from baseline Adjusted between group
difference, mean (95% CI)
P ES
RYGB ILI
(n=76) (n=63)
Physical dimensiona 16.8 (9.7) 4.9 (9.4) 8.6 (4.6,12.6) <.001 .83
Mental dimensiona 9.6 (9.1) 3.5 (8.9) 5.4 (1.5,9.3) .007 .50
Emotional dimensionb 42.7 (25.5) 15.7 (21.7) 25.2 (15.0,35.4) <.001 1.06
Number of obesity symptomsc −5.3 (4.6) −2.9 (4.7) −2.3 (−4.5,-.6) .012 .56
Symptom distressd −25.2 (20.7) −14.3 (16.5) −8.7 (−15.4,-1.8) .013 .37
Adjustments were made for age at the onset of obesity and baseline values of age, BMI physical activity level, and HRQL. (a) SF-36 (scale 0–100). (b) OWLQOL
(scale 0–102). (c) WRSM (scale 0–20). (d) WRSM (scale 0–120). Statistical significance (P) and effect size (ES) are reported.
Figure 3 Mean scores on five HRQL-scales at baseline and 1 year in morbidly obese patients who underwent a part residential
intensive lifestyle intervention program (n=63). (a) SF-36 Physical dimension (0–100). (b) SF-36 Mental dimension (0–100). (c) OWLQOL
Emotional dimension (0–102). (d) WRSM symptom number score (0–20). (e) WRSM symptom severity score (0–120). Unadjusted mean change
scores and 95% CI. P and ES-values for within-group changes.
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coronary artery disease, group support was reported to
be associated with a significant improvement in the
mental dimension of HRQL despite moderate weight
loss [31].
The self-reported symptom scores before treatment
in both groups corroborate the well-known associ-
ation between high BMI, several comorbidities and
physical HRQL. After 1 year we found that patients
in both groups reported significantly fewer symptoms.
The improvements in joint pain and physical stamina
in the RYGB group were notable and may, together
with improvements in skin irritation, water retention,
foot problems, and shortness of breath, have resulted
in easier performance of everyday personal hygiene,
housekeeping, shopping and walking. All these tasks
are central elements of the physical dimension of
HRQL [11], which in the RYGB group showed a large
effect size (ES=.83).
Another distressing obesity-associated symptom is
snoring and tiredness. These symptoms were markedly
reduced in the RYGB group. This finding supports a re-
port from the SOS-study which found a substantial re-
duction in symptoms of sleep apnoea and daytime
sleepiness in the bariatric surgery group after 2 years
[32]. One might speculate that increased sleep quality
and reduced daytime sleepiness may lead to increased vi-
tality and improved functioning at work or during other
daily activities, which also is embedded in the physical
dimension of HRQL [11]. The finding of increased sensi-
tivity to cold in the RYBG group is probably connected
to the higher loss of fat mass with surgery [33], and
Figure 4 Mean scores on five HRQL-scales at baseline and 1 year in morbidly obese patients who underwent RYGB (n=76). (a) SF-36
Physical dimension (0–100). (b) SF-36 Mental dimension (0–100). (c) OWLQOL Emotional dimension (0–102). (d) WRSM symptom number score
(0–20). (e) WRSM symptom distress score (0–120). Unadjusted mean change scores and 95% CI. P and ES-values for within-group changes.
Table 3 1-year changes in reported symptom distress
between groups of morbidly obese patients undergoing
RYGB (n=76) or intensive lifestyle intervention (n=63)
Symptom RYGB ILI P ES
Physical stamina −2.7 (2.5) -.7 (2.6) <.001 .913
Pain in the joints −2.4 (2.2) -.7 (2.0) .002 .891
Snoring −2.3 (2.2) -. 8 (2.0) .002 .721
Sensitivity to cold 1.4 (2.2) .1 (1.9) .005 .921
Skin irritation −1.2 (1.9) -.3 (1.8) .032 .493
Sleep problems −1.3 (2.2) -.4 (2.2) .043 .406
Water retention −1.5 (1.9) -.6 (2.0) .047 .456
Foot problems −2.2 (2.6) −1.1 (2.5) .050 .541
Back pain −1.6 (2.0) -.9 (1.7) .071 .350
Tiredness −1.6 (2.2) -.7 (2.2) .089 .460
Shortness of breath −2.2 (2.1) −1.4 (1.9) .093 .442
Leakage of urine -.8 (1.6) -.3 (2.0) .220 .267
Frequent urination -.8 (2.1) -.3 (1.7) .281 .244
Increased sweating −1.3 (2.1) -.9 (2.2) .339 .246
Loss of sexual desire −1.4 (2.6) -.9 (2.6) .393 .215
Lightheadedness .3 (1.8) -.2 (1.5) .517 .164
Increased thirst -.9 (1.9) -.7 (1.8) .569 .136
Increased irritability -.4 (2.1) -.7 (2.1) .595 .140
Increased appetite -.2 (2.2) -.3 (2.0) .849 .044
Sensitivity to heat −1.5 (2.4) −1.6 (2.2) .987 .004
Self-reported data from the Weight-related Symptom Measure (WRSM). Scale
from 0 (bothers not at all) to 6 (bothers a very great deal). Data are given as
given as mean difference in scores (SD). P and ES-values for
between-group differences.
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is a phenomenon commonly observed within clinical
practice.
The overall reduction of the number of symptoms and
symptom distress in the ILI group was statistically sig-
nificant, although with moderate effect sizes. However,
compared to the RYGB group more patients in the ILI
group were physically active at baseline, whilst the in-
crease in physical activity after one year was larger in
the ILI group than the RYGB group [9]. We believe that
the combination of the overall reduction in symptom
distress and higher activity levels contributed to an im-
provement of the physical HRQL in the ILI group, even
though the weight loss was moderate. There is a consist-
ent association of higher HRQL scores with higher levels
of physical activity among healthy adults in cross-
sectional studies [34], and this association is stronger on
the physical dimension of the HRQL than the mental di-
mension [34]. We also know that interventions combin-
ing physical activity and diet improve the physical
dimension of HRQL but not the mental dimension
among older obese individuals with knee ostoearthritis
[35].
As with the emotional and physical aspects of HRQL,
the mental aspects also improved in both groups after 1
year. The RYGB group scored significantly better than the
ILI group. Other studies have found similar results [7,8]
between bariatric surgery and non-standardised lifestyle
programs. However, our study extends previous findings
to include the comparative effects of a structured, system-
atic part residential lifestyle program. The improvements
in the mental dimension of HRQL may be explained by
the greater weight loss and improvement of psychosocial
status including social relations and employment oppor-
tunities [36]. A deeper understanding of the relationship
between weight loss and improvement of the emotional
and mental dimension of HRQL may necessitate research
designs other than a quantitative approach.
We have previously shown [9] bariatric surgery to be su-
perior to lifestyle treatment in regards to weight loss.
However, the effect of weight loss on improvement of
HRQL may have been moderated by the lifestyle treat-
ment regime itself. In particular, our results suggest that a
“comprehensive and multidisciplinary program intended
to increase the patient’s self-efficacy in dealing with their
weight problem” may impact upon HRQL, independent of
weight loss.
As reported earlier our study has limitations [9]. Al-
though preferable when conducting a clinical trial, we
did not find randomization to be appropriate. According
to Norwegian guidelines, treatment seeking morbidly
obese subjects should be offered either conservative or
surgical therapy. We therefore considered it unethical to
assign patients to surgery if they qualified for a lifestyle
intervention program and preferred this course of
treatment to surgery. This stance also held vice versa.
Thus, the differences between the groups may not be
causally associated with choice of treatment. Further, the
study was limited to a 1-year time span. The long term
effects of the two interventions on HRQOL may differ
due to intervening life events, complications of surgery,
or other reasons, and these require further study.
Lifestyle intervention for morbid obesity comprises of
many different methods, from very low calorie diets to
comprehensive psychosocially oriented programs com-
bining diets, physical activity and behavioral interven-
tion. There is little robust evidence identifying the most
effective lifestyle strategies for treatment and prevention
of obesity in general and in morbid obesity in particular
[37]. Hence, research must focus on a variety of lifestyle
intervention programs in order to to identify the most
beneficial treatment regimens. Our findings indicate
that a pre-defined part residential multidisciplinary
non-surgical weight loss program with a psychosocially-
oriented motivational approach is a promising interven-
tion when aiming to increase HRQL in morbidly obese
patients. However, larger weight losses may be necessary
to maximize the beneficial effects.
Conclusion
Our study shows that following a part residential multidis-
ciplinary lifestyle intervention program, morbidly obese
patients improved their HRQL, although patients under-
going bariatric surgery experienced larger improvements
in HRQL after 1 year. The higher clinical relevance of
bariatric surgery on HRQL may be explained by a higher
weight loss.
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